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The eye as target for topical drug delivery – overcoming the problems 
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Introduction 
Anatomy 
 
Anatomy of the eye 
The eye is the organ for visual perception of the environment. In order to forming a 
picture, a perceptive and a refractive system is needed. The perceptive system is 
located in the rear part of the eye, while the refractive system is mainly located in the 
anterior part. 
Figure 1 gives an overview on the architecture of the eye. 
 
Figure 1: Anatomy of the eye [adapted from ref. 1] 
 
The shape of the eyeball is crucial for the proper function of the eye. Therefore, its 
shape sustained by a system composed of an outer shell that is build of various layers 
of tissue and an additional inner support, the vitreous body. The outmost tissue layer 
of the eye is the tunica externa oculi and it mainly consists of connective tissue, called 
Sclera 
Choroids 
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sclera. The sclera has a white appearance and is made of collagen. The front part of 
this outer shell is the cornea, which is incremented to the sclera in an hourglass-like 
fashion. The cornea is clearly distinguishable from the sclera and has different 
properties, of which the optical (refractive) and barrier function are the most 
important ones. 
 
The middle layer of the eye is called uvea and consists of choroids, iris and ciliary 
body. The choroid contains a big amount of blood vessels and is responsible for the 
nutrition (i.e., supply with oxygen, minerals and other nutrients) of the adjacent 
tissues. Connected to the choroids is the ciliary body, which is responsible for the 
accommodation of the lens. It also regulates the intraocular pressure by disposing the 
aqueous humor through the Schlemm’s channel. Third part of the uvea is the iris. It 
consists of two important smooth muscles, called musculus sphincter pupillae and 
musculus dilatator pupillae. These two muscles control the opening and closing of the 
pupilla, depending on light intensity on the retina. 
Furthermore, the iris has a pigmented epithelium that determines its color. The 
epithelium is visible from the outside and is a personal feature, commonly known as 
eye color. Besides the control of light intensity entering the eye and giving the eye 
color, the iris serves as a barrier between the anterior and the posterior part of the eye. 
Thus, it creates the anterior chamber and posterior chamber that contain the aqueous 
humor. 
 
The inner parts of the eye consist of anterior chamber, lens, vitreous body and retina. 
The retina is the innermost layer of the bulbus and is the perceptive system of the eye. 
Through photochemical processes in the light sensitive cells (i.e., rods and cones) 
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nervous impulses are generated that will be transformed to a picture in the brain. 
Through the high density on pigmented cells, the retina has a dark-brown to black 
appearance. 
The vitreous body mainly helps maintain the spherical shape of the eyeball. 
The lens is, besides cornea, the second part of the refractive system that directs light 
to the perceptive part of the retina. The curvature of the lens is controlled by the 
ciliary body. 
The anterior chamber is the liquid-filled part between cornea and iris. It is mainly 
responsible for the intraocular pressure of 10-21 mm Hg. 
 
Anatomy of the cornea 
 
Figure 2: The layers of the corneal epithelium [taken from ref. 2] 
 
The cornea has two main characteristics. On the one hand, it is part of the refractive 
system and directs, together with the lens, light towards the macula lutea on the retina. 
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To serve this property, it is necessary that the cornea has a clear appearance. This is 
achieved by a high degree of hydratization and the absence of blood vessels [5]. 
Nutrients are delivered to the cornea by diffusion only. On the other hand, it 
represents the barrier between the anterior chamber and the air in the outside 
environment. This makes the cornea an important part of the protective system of the 
body, because it prevents substances and microorganisms from entering the eye. 
Histologically, the structure of the cornea is rather simple. As shown in figure 2, it 
consists of a multi-layered epithelium, two membranes, a stroma and a single-layered 
endothelium. 
 
The human epithelium itself consists of 5-6 cell layers, but the thickness varies 
between species and can easily exceed the numbers found for humans. The innermost 
layer is the basal cell layer. This monolayer contains living cells with mitotic activity. 
Cells are produced continuously. During their life span of about 14 days, epithelial 
cells differentiate and travel to the surface of the epithelium, becoming first wing cells 
(2-3 cell layers) and then superficial cells with a very long and flat appearance. The 
superficial cells completely lack proliferative activity [6]. The surface of the cornea is 
highly increased by mircoplicae and microvilli. The epithelial layers also contain a 
high number of nervous endings that produce the feeling of major discomfort if the 
eye is rubbed or scratched. Tight junctions between neighboring cells of the 
epithelium are essential for the protective properties of the cornea and also for the 
maintenance of corneal transparency [3, 4] 
 
Basis for the epithelium is Bowman’s membrane. It mainly consists of type I and III 
collagenous fibers. The actual purpose of this membrane is still unclear, especially 
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because not all mammals have a Bowman’s membrane. But in humans, the 
importance of this layer for structural integrity of the epithelium has been shown. The 
body does not have self-repair mechanisms for the Bowman membrane [7]. 
 
Almost 90% of the cornea consists of stroma. This middle layer consists of water and 
collagen type I (90%), III (<10%), and V (traces) [8]. The collagen is produced by 
fibroblasts that are embedded in the stroma. The organization of the collagen fibrils is 
crucial for the transparency of the cornea. 
 
Descement’s membrane serves as basal layer for the endothelium. It consists of 
collagen type IV, fibronectin and laminin [8]. 
 
The endothelium is the innermost layer of the cornea and the barrier to the aqueous 
humor. It controls substance diffusion and nutrition of the upper layers. It is a tight 
layer through formation of cell-cell-contacts, but not the major barrier in the cornea. 
The normal density is about 3,500 endothelial cells/mm2. 
 
 
Targets for ocular drug delivery 
The treatment of ocular diseases is in general pursued by local, topical application of 
medical drugs. Carriers for the drugs are usually eye drops or eye ointments. 
For the drug, the hydrophilicity/lipophilicity ratio determines the penetration of the 
substance. Hydrophilic substances will stay on the surface of the eye, accumulating in 
the tear film. Highly lipophilic substances will penetrate the corneal epithelium but 
are unable to cross the hydrophilic stroma. For these substances, other routes of 
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penetration, like distribution through the local vasculature, are reserved [9]. 
Amphiphilic substances do have the properties to cross the various corneal 
compartments with different characteristics (i.e., lipophilic or hydrophilic 
corresponding to corneal epithelium and endothelium or stroma) and penetrate into 
the inner eye. 
 
In the eye, there are application possibilities for both, hydrophilic and lipophilic 
drugs. Pharmaceutical treatment of the eye surface includes (allergic) conjunctivitis, 
dry eye disease, bacterial infections of the eyelid limbus (i.e., hordeolum), local 
anesthesia and cornea ulcers. 
Pathological conditions of the inner eye are glaucoma, age-related macula 
degeneration (AMD), eye infections with bacteria, viruses and fungi, cataract and 
retinal detachment. 
This makes aqueous humor/ciliary body, lens and retina to major targets for ocular 
drug delivery in the inner eye. 
 
For an amphiphilic substance, there are 3 general ways of drug delivery. The first 
possibility is the general blood circulation that will distribute the substance in the 
systemic circulation and, following drug distribution in the body, also reach the eye 
locally. 
Another pathway is the penetration via the conjunctival-scleral pathway that includes 
distribution of the substance along the conjunctiva and re-entry of the compound into 
the eye through the sclera [9]. The conjunctival-scleral pathway is restricted to some 
compounds of high molecular weight. Even though it contributes highly to the drug 
delivery of these compounds, it is of minor interest for general ocular drug delivery. 
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The most common way of drug penetration is the direct pathway through the cornea, 
which makes this compartment of the eye a major barrier for ocular drug delivery. 
Drug penetration in the cornea has two possible pathways: crossing the cellular body 
(i.e., transcellular) or through the gaps between the cells (i.e., paracellular). For 
paracellular transport, tight junctions between the uppermost layers of the superficial 
cells form a major barrier for penetration [10]. More hydrophilic drugs can only cross 
the barrier by using pores in the cell layer. The tight junctions regulate the 6nm-sized 
openings. More lipophilic drugs have the properties for transcellular penetration. The 
lipophilicity ratio has been shown to be a crucial factor for transcellular transport by 
Schoenwald and others [11]. The different pathways through cellular layers are shown 
in Figure 3. The most important ways of drug penetration in corneal tissue are shown 
on the left hand side. 
 
 
 
 
 
 
 
Figure 3: Penetration pathways in (cultured) cell layers 
 
Besides the physico-chemical properties of the active ingredient, several other aspects 
affect the delivery of drugs to the eye. As an important factor, the short residence time 
for ocularly applied solutions has to be considered. This is caused by the small total 
volume of the cul-de-sac and rapid drainage of the liquid through the nasal duct. Thus, 
apical 
(luminal) 
basolateral 
(serosal) 
1 transcellular transport 
2 paracellular transport 
3 vesicular transport 
4 active absorption 
5 active sectretion 
6 active efflux systems 
   (e. g., P-gp) 
      
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for an ocular drug preparation, viscosity, mucoadhesive properties, applied volume 
and moistening are crucial factors. 
 
In vitro models to study drug absorption 
Drug delivery research has gained a new tool in the last decades: many 
pharmaceutical scientists use in vitro cell cultures as novel strategy to exploit drug 
delivery issues. The various advantages of in vitro cell cultures in pharmaceutical 
development and research include (1) rapid assessment of the potential permeability 
and metabolism of a drug, (2) the opportunity to elucidate the molecular mechanisms 
of drug transport or the pathways of drug degradation (or activation), (3) rapid 
evaluation of strategies for achieving drug targeting, enhancing drug transport, and 
minimizing drug metabolism, (4) the opportunity to use human rather than animal 
tissues, (5) the opportunity to minimize time consuming, expensive, and sometimes 
controversial animal studies. The reduction of animal experiments is in accordance 
with the 3 R principles, firstly introduced by Russell and Burch in 1959 [12]. The 3 
R’s stand for Replace, Reduce and Refine and are guidelines for the application of 
animal experiments in scientific research. In a sense of animal welfare, cost reduction 
and a wish for increased reproducibility of experiments, the replacement of animal 
experiments by suitable in vitro test systems has become important in the last decades. 
In an effort to pursue this scope, an array of cell culture models for epithelial barriers 
has been established, including models of the intestinal, rectal, buccal, sublingual, 
nasal, ocular epithelium and the epidermis of the skin [20]. Especially, the epidermal 
cell models (i.e., reconstituted epidermis) and the intestinal epithelium (i.e., Caco-2 
cell cultures) have gained major acknowledgement in scientific research. But also the 
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cell culture models of the ocular barriers provide powerful systems to investigate the 
barrier properties of the eye in vitro. 
Generally, two types of cell culture systems have to be distinguished: primary cell 
culture and continuous (immortalized) cell lines.  
Primary cultures are derived from cells, tissue or organs that were explanted directly 
from the donor organism. After purification and selection steps, the cells are seeded 
onto suitable supports and cultured throughout their lifecycle. No steps for extending 
the useful lifespan are undertaken. Generally, subculturing of primary cells is 
possible, but the number of passages is limited due to the limited lifespan. 
The limited viability of the cells is seen as a major disadvantage of the primary 
culture, along with limited availability of the original tissue. The high resemblance of 
the cells to the original tissue or organism is considered advantageous in return. 
Continuous cell lines, also often referred to as immortalized cell lines, have 
undergone a procedure to extend their useful lifespan beyond their physiological 
lifecycle. Immortalization often includes the insertion of additional genomic 
information to the cell and goes along with a decrease in the status of differentiation. 
The advantages of continuous cell lines include the uniform characteristics, almost 
unlimited self-reproduction of the cells and easy handling. Disadvantages of these 
models include the lower state of differentiation when compared to primary cells and 
resulting from this, the reduced resemblance to the original tissue or organism. Figure 
4 shows a general example of cells cultured on a suitable, permeable filter membrane. 
A selection of continuous cell lines representing the corneal epithelium has already 
been established [13, 14, 14, 16, 17]. Since all these cell lines have undergone a 
process to extend their lifespan and are partly of non-human origin, they often lack 
certain features that are only found in human primary cells. Among these features is 
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epithelial phenotype, state of differentiation, formation of tight junctions, 
morphological appearance, and presence or absence of membrane transporters. 
Primary cell cultures are expected to develop a tight barrier in culture and resemble 
the in vivo barrier best by a process of formation of a tight cell layer, differentiation, 
morphological and functional resemblance. Primary cultures are gained by isolation 
of the respective cells from the respective (here: corneal) tissue. The fresh cells are 
maintained in a suitable cell culture medium for a certain time. Since primary cells are 
in the regular cell cycle, their lifespan is not extended and these cells are mortal. 
Primary ocular cell cultures, suitable for drug transport studies, have already been 
established using rabbit corneal epithelial and conjunctival epithelial cells [18, 19]. 
Taking in account the principles and techniques mentioned above, a wide array of 
useful cell culture models of the corneal epithelium has been established. The ban of 
animal testing in the cosmetics industry by the European Union in 2003 contributed to 
the immense development and improvement of (ocular) cell cultures. Major target 
was to substitute animal experiments by suitable in vitro methods. Many of these cell 
culture models focus on toxicity testing and ocular irritation, but also cell layers for 
drug permeation studies are available. Indispensable for successful drug penetration 
testing is a cell layer that exhibits a tight epithelial barrier, which disqualifies some of 
the models of the corneal epithelium that were established as substitute for the Draize 
test. Still, at least two cell lines are available for pharmaceutical purposes (see later 
chapters). 
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Figure 4: macroscopic (A) and microscopic (B) images of in vitro cell models 
 
 
Bioelectrical parameters 
To evaluate the barrier properties of in vitro models, two parameters are generally 
monitored: The transepithelial electrical resistance (TEER) and the potential 
difference (PD). While the TEER value is an indicator for the tightness of the 
(epithelial) barrier, generated by the cells and their tight junctions, the PD represents 
the activity of ion-transporters. The TEER is usually expressed in Ω*cm², the PD in 
mV, which allows to standardize and transfer the measured values to various barrier 
and cell systems. Both values are corrected for a background, contributed by the filter 
membrane of in vitro cell culture systems (TEER value) or the conductance of the 
medium (PD). 
TEER and PD are measured best with an electrical voltohmmeter equipped with 
“chopstick” electrodes that suit the permeable cell culture inserts (e.g., Corning 
Transwell®, Greiner Thinserts®, NUNC CC Inserts®). A suitable device is provided 
by World Precision Instruments (EVOM with STX-2 electrodes). The device is shown 
in figure 5. TEER values are also assessed as standard procedure in the experiments 
described herein to control the integrity of the cell layers and tissues used. 
(A) (B) 
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Figure 5: Scheme of an EVOM device and its application [photo taken from the WPI 
web page] 
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Aim of this work 
This work focuses on several aspects of ocular drug delivery research. On the one 
hand, a new therapeutic compound, moxaverine-hydrochloride, should be examined 
for its penetration behavior into the eye and its various tissues, on the other hand, a 
suitable cell culture system should be established to facilitate drug delivery research 
and reduce the number of animal experiments. 
In this work, an attempt was made to establish a primary human corneal epithelial cell 
model as a tool for drug penetration studies. 
Since, as already mentioned, a human in vitro system resembles the in vivo situation 
best, the set-up of a human primary corneal epithelial cell model is highly interesting 
for scientific and biopharmaceutical research. 
To evaluate the available cell culture models, a comparison of the different properties 
of the various cell models is another scope of this work. So far, different cell culture 
systems for different applications are used side-by-side in research. To find the model 
most suitable for drug transport studies, we compared the different cell culture models 
for the first time using identical conditions. 
 
According to this scope, the presented thesis is subdivided in 5 chapters, each dealing 
with a different aspect of the evaluation of the cell culture system and our new drug 
compound, moxaverine-hydrochloride: 
1. The in vivo evaluation of moxaverine-hydrochloride, its ocular distribution 
and bioavailability are examined in Chapter 1. 
2. In Chapter 2, the studies undertaken to establish a human primary corneal cell 
culture model are summarized. 
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3. For the comparison and evaluation of different corneal cell models, drug 
transport studies, employing a portfolio of different marker substances, were 
performed. Chapter 3 discusses the findings of the study and scores the 
different systems under investigation. 
4. In Chapter 4, the commonly used HCE-T cell model is compared to our ex 
vivo system, generated using excised human cornea. Differences in the 
molecular-biological layout are pointed out. Main focus of this chapter is on 
the MDR-transporter spectrum. 
5. Further examinations and findings are summarized in Chapter 5. 
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Tissue Distribution of Moxaverine-Hydrochloride in the Rabbit Eye and Plasma 
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Ulrich Becker, Carsten Ehrhardt, Ulrich F. Schaefer, Hovhannes J. Gukasyan, 
Kwang-Jin Kim, Vincent H. L. Lee and Claus-Michael Lehr (2005) Tissue 
Distribution of Moxaverine-Hydrochloride in the Rabbit Eye and Plasma. J Ocul 
Pharmacol Ther 21: 210-216 
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Abstract 
 
Objective: The aim of this study was to determine the tissue distribution and epithelial 
penetration of moxaverine-hydrochloride (MOX) in the rabbit eye. 
Methods: For systemic application, a radioactively labeled MOX solution was 
injected into the ear vein of Dutch-belted pigmented male rabbits. For topical dosing, 
an identical solution was administered. At pre-determined time points, rabbits were 
sacrificed, the eye dissected, and the amount of MOX in the ocular tissues measured. 
To examine the MOX permeability across the corneal epithelium, transport studies 
using rabbit corneal epithelial cell culture were conducted and the respective apparent 
permeability coefficient in absorptive (a to b) or secretive (b to a) direction was 
calculated. 
Results: Topical delivery resulted in high concentrations of MOX in cornea and 
conjunctiva, while other tissues of the anterior part yielded lower MOX 
concentrations. In the tissues of the posterior part, high amounts were detected in the 
retina. Plasma levels were low. The apparent permeability coefficient across corneal 
epithelial cell layers was in the range of 10-5 cm/s, exhibiting no apparent 
directionality. 
Conclusions: A topical dosing of MOX to posterior regions of the eye seems feasible. 
MOX levels in the posterior part of the eye were remarkably high, without causing 
stringent plasma levels. The high apparent permeability coefficient of MOX across 
the corneal epithelial cell layers might be due to the lipophilic nature of the drug and 
was in the range of other compounds with comparable physicochemical properties. 
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Introduction 
 
Targeting drugs to the posterior part of the mammalian eye via topical application 
remains a formidable task and is of major interest for ophthalmic research, because of 
the easy application for the patient and considerably low systemic availability, which 
might alleviate unwanted side effects. 
In addition, to opt for the ocular route of drug delivery might avoid drug 
degradation caused by the first pass effect occurring in the liver. Moreover, it is 
possible to target drugs to several sites or tissues of interest [1]. 
Potential disadvantages of ocular drug delivery may include the rather low 
applicable volume and the rapid drainage of the drug solution through the naso-
lacrimal duct. The comparison of advantages and disadvantages of topical (ocular) 
dosing and systemic application is a rewarding field of research, as is the evaluation 
of the distributional profiles of old and new drug entities. 
Moxaverine-hydrochloride (MOX) is a derivative of papaverine-hydrochloride, a 
component of the chyle of the poppy (papaver somniferum) used as muscle relaxant, 
but its efficacy in the ophthalmic clinic is unknown. Compared to papaverine-
hydrochloride, MOX offers enhanced solubility in hydrophilic or aqueous solvents 
and a lower toxicity [2,3]. The chemical structure of MOX is shown in Figure 1.  
 
N
MeO
MeO
ClH
MW: 343.85
 
Figure 1: Chemical structure of moxaverine-hydrochloride 
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The synthesis of MOX (1-benzyl-3-ethyl-6, 7-dimethoxy-isoquinoline) was first 
described in 1962 [4]. 
Physicochemical properties of interest for MOX include a high lipophilicity (log 
PpH 7.4= 4.017), a pKA-value of 6.75 for the nitrogen-atom and a high amount of 
protein binding.  
In the clinic, the hydrochloride-salt is used instead of the free, lipophilic base, due to 
its increased solubility. The pharmacodynamic effects of MOX include: increased 
rheology of erythrocytes; blood vessel relaxation in the brain as well as in the 
peripheral organs (e.g., arms and legs); and spasmolysis of the vessel musculature 
[5,6]. The vessel relaxation and spasmolytic properties of MOX seem to be of major 
interest in ocular application, in addition to the decreased viscosity of the blood, 
which is useful in therapy of circulatory disorders. Other mechanisms of action 
include an inhibition of the enzyme phosphodiesterase (PDE) [6 - 11] and coupling 
with calmodulin resulting in a stronger inhibition of the calmodulin dependant PDE 
[12, 13].  
In recent years, considerable efforts have been made to develop in vitro models 
that allow reliable mechanistic examinations of cellular and molecular processes 
involved in the absorption of xenobiotics. The gastrointestinal tract has been 
examined for that purpose very intensively, whereas ocular cell culture models have 
also been used as a tool to examine drug transport mechanisms. In this context, 
protocols have been developed for the isolation and cultivation of primary corneal and 
conjunctival epithelial cells [14, 15] and continuous cell lines have been established 
[16, 17]. Because cells in primary culture resemble the native tissue closer than cell 
lines, we also conducted our studies using primary cultured corneal epithelial cells 
isolated from male, Dutch-belted pigmented rabbits. Culture conditions are known to 
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be highly relevant for proliferation and differentiation of various epithelial cells. 
Adapting from the culture techniques for airway epithelial cells [18, 19], air-interface 
culture (AIC) of ocular epithelial cell models yielding a very tight and well-
differentiated cell layer [14, 15], has been developed and utilized in our laboratories. 
In this study, we determined whether MOX, a drug of potential interest for 
ophthalmic treatment/research, could be delivered to tissues of interest by topical 
application to the eye and also estimated the apparent permeability coefficients across 
the primary cultured corneal epithelial cell layers. 
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Materials and methods 
 
Materials 
Moxaverine-hydrochloride (MOX) was a gift from Ursapharm Arzneimittel 
GmbH & Co. KG (Saarbrücken, Germany). 14[C]-Radiolabeled MOX (specific 
activity 30 mCi/mmol) was synthesized by BIOTREND (Cologne, Germany). All 
other materials were of the highest grade available commercially. Eutha-6 CII sodium 
pentobarbital solution was purchased from Western Medical Supply (Arcadia, CA). 
Triton X-100, anhydrous citric acid, protease type XIV and DNase I were from Sigma 
(St. Louis, MO). Sodium hydroxide was from Curtin Matheson Scientific (Houston, 
TX) and PBS (10x) from Gibco (Grand Island, NY). Scintillation cocktail (Econo-
Safe) was purchased from Research Products Intl. (Mount Prospect, IL) and heparin 
5000 IU/mL from Elkins-Sinn (Cherry Hill, NJ). Transwell filter inserts (catalog 
number 3460) were from Costar (San Francisco, CA). Male, Dutch-belted pigmented 
rabbits, weighing ~ 2.2 kg, were purchased from Irish Farms (Los Angeles, CA). The 
animals were utilized according the ARVO Statement for the Use of Animals in 
Ophthalmic and Vision Research. 
 
Methods 
 
In vivo administration: 
For the in vivo studies, 10 mL of a citrate buffer (44.06 mM citric acid, 80.6 mM 
NaOH, pH = 3; 280 mOsm) were spiked with 11 µL MOX-radiotracer. The total 
concentration of MOX in the eye drop preparation was 1.28x10-3 M. The 
concentration was chosen to make the achievement of significant concentrations in 
the aqueous humor most likely. The iso-osmotic pressure mainly limited the 
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concentration of MOX in the eye drop preparation. However, 10-7 M has been found 
to be a minimal active concentration by Berndt et al. [8] using a porcine ateria 
femoralis preparation. A modification of the protocol of Schoenwald and Steward 
[20] was used for ocular administration. Briefly, the rabbits were placed in restrainers 
and 50 µL of the isotonic drug solution, spiked with a radioactive tracer as described 
above, was topically applied to each eye. For the determination of the drugs 
bioavailability after intravenous administration, an identical solution was injected to 
the marginal ear vein of the animal. At predetermined time points up to 120 min, 
blood samples were taken from the artery in the central region of the rabbit ear. Blood 
coagulation was prevented with heparin and the blood cells were separated from 
plasma by centrifugation. Subsequently, rabbits were sacrificed by an overdose of 
Eutha-6 CII given intravenously. From one eye, samples of aqueous humor and 
vitreous body were taken; the other eye was excised as a whole from which various 
ocular tissues (e.g., cornea, conjunctiva, lens, iris/ciliary body, retina, sclera) were 
dissected. For the isolation of retina and sclera, the vitreous body was removed from 
the eye using a pair of forceps. Subsequently, the outer tissues were flattened by eight 
incisions along the sclera-iris-rim. The retina, containing the choroids, was scraped 
off using a scalpel blade. 
 
Individual tissues were then lysed with 1 mL solubilizer mixture (comprised of Triton 
X-100 (15% v/v) and 0.5 N NaOH) for 12 hours. Scintillation cocktail was added to 
the vials containing the individual tissue lysates and the radioactivity of each lysed 
tissue sample was determined in a scintillation counter (LS 1801, Beckman, Fullerton, 
CA). 
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In vitro permeability studies: 
A primary culture of rabbit corneal epithelial cell layers (rbCrECL) was used. This in 
vitro model has been described previously by Chang et al. [14] and has been slightly 
adapted for our purposes. Briefly, pigmented male Dutch-belted rabbits were 
sacrificed by an intravenous overdose of Eutha-6 CII solution (120 mg pentobarbital-
sodium/kg body weight) via the marginal vein of the left rabbit ear. The entire eye 
was carefully removed by an aseptic method. The corneal epithelial cell layers were 
exposed to a 0.2% solution of protease type XIV for 45 min at 37°C before being 
gently scraped off. Protease activity was stopped by adding supplemented minimum 
essential medium (S-MEM) containing 10% fetal bovine serum (FBS). The addition 
of excess proteins caused a quenching of enzymatic activity. The following removal 
of the medium completely disposed of the protease. 
Cell aggregation was reduced by including 0.75 mg/mL DNase I in the same 
solution. Isolated cells were washed and purified further by passing them through a 
40-µm cell strainer. The resulting corneal epithelial cells (viability >95%, tested by 
trypan blue exclusion assay) were then plated onto 1.13 cm2 polyester Transwell filter 
inserts (12 mm in diameter, pore size 0.4 µm), precoated with a mixture of rat-tail 
collagen (type I, 1.8 µg/cm2) and human fibronectin (0.6 µg/cm2). DMEM/F12, 
supplemented with penicillin (100 U/mL), streptomycin (100 µg/mL), gentamicin (50 
µg/mL), insulin-transferrin-selenium premix (10 µL/mL ITS+, BD Biosciences, San 
Jose, CA), bovine pituitary extract (30 µg/mL), epidermal growth factor (EGF, 1 
ng/mL) and hydrocortisone (0.36 µg/mL), was used as culture medium. Cells were 
maintained in a humidified incubator at 37°C in 5% CO2 atmosphere. Air-interfaced 
culture (AIC) conditions were created by removing media from the apical 
compartment and keeping 700 µL of media in the basolateral compartment starting 
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one day after cell plating. Culture media were changed on a daily basis after 
bioelectrical parameters were assessed. The bioelectric parameters of transepithelial 
electrical resistance (TEER) and potential difference (PD) were measured with an 
epithelial voltohmmeter (EVOM), equipped with STX-2 chopstick electrodes (World 
Precision Instruments, Sarasota, FL). TEER and PD were corrected for the 
background values contributed by the empty filter and culture medium.  
 
Transport studies: 
In vitro transport experiments were performed on day 7 to 10 in culture. All 
solutions were used prewarmed to 37°C. The cell layers were washed with a modified 
Krebs-Ringer solution with bicarbonate buffer (KRB, 1.5 mM K2HPO4, 3 mM KCl, 4 
mM glucose, 142 mM NaCl, 10.07 mM 4-(2-Hydroxyethyl)-piperazine-1-
ethansulfonic acid (HEPES), 1.4 mM CaCl2, 2.56 mM MgCl2, pH = 7.4). The 
transport experiments were initiated by exchanging the KRB of the respective donor 
side with a same volume of isotonic radiolabeled MOX solution (1mCi 14C-MOX / 
L). The volumes in the apical and basolateral chamber were, respectively, 500 µL and 
1500 µL. 
Samples (100 µL) were drawn from the corresponding receiver compartment 
every 30 minutes up to 3 hours. Sampled volumes were replaced by the same amount 
of fresh pre-warmed KRB solution. Samples were mixed with scintillation cocktail 
and assayed for their radioactivity using a scintillation counter. To determine the 
initial concentration, 20-µL samples of the test solution were assayed for 
radioactivity. 
All transport experiments were performed with and without addition of 
benzalkonium chloride/EDTA, a potential preservative. Concentrations for the 
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preservatives were chosen according to recommendations given in the German Drug 
Codex (DAC) [23], that is, 0.01 % (w/v) for benzalkonium chloride and 0.2% (w/v) 
for EDTA.  
Experiments were performed in triplicate. Both TEER and PD values were 
assessed before and after the drug permeation experiments to assess the integrity of 
the cell layers. 
The apparent permeability was calculated as flux of MOX versus time, using the 
relation,  
Ac
JPapp
*0
=    (Eq. 1) 
where, J = MOX flux (mol/s), c0 = initial MOX concentration in the donor solution 
(mol/cm3) and A = surface area of the cultured corneal epithelial cell layer (cm2). 
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Results 
 
In vivo experiments: 
The results of the in vivo study of MOX accumulation in the anterior (i.e., 
conjunctiva, cornea, aqueous humor, iris and ciliary body, lens) and posterior parts 
(i.e., sclera, retina) of the eye are respectively shown in Figures 2 and 3. Drug 
amounts found in the plasma (representing systemic bioavailability) are also given in 
Figure 3.  
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Figure 2: Tissue distribution of moxaverine-hydrochloride in the anterior parts of 
the eye following systemic vs. ocular delivery. Experiments were performed on 3 
rabbits for each time point, except for systemic application 30 min (n=2).  
The error bars reflect standard deviations. 
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Target structure
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Figure 3: Tissue distribution of moxaverine-hydrochloride in the posterior parts of 
the eye and plasma. Experiments were performed on 3 rabbits for each time point, 
except for systemic application 30 min (n=2). 
The error bars reflect standard deviations 
 
After topical administration, the highest levels of MOX were found in the anterior 
parts of the eye, i.e., conjunctiva, cornea and iris/ciliary body. The lens and aqueous 
humor contained no measurable amounts of drug. 
For the posterior parts of the eye, the MOX concentration within the retina at 30 
min after topical administration was slightly lower than those attained via systemic 
application. After 2 hours, drug content of the retina decreased after systemic 
application, whereas drug content increased in the same tissue after ocular dosing. It 
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should be noted that the plasma values after topical dosing are significantly lower 
compared to those observed with systemic dosing. 
Amounts of MOX in the sclera at both 30 and 120 min in after intravenous 
application, were lower than those found with ocular administration.  
 
In vitro experiments: 
The results of the in vitro transport studies conducted with primary rabbit corneal 
epithelial cell layers are shown in Table 1. The Papp values for both absorptive and 
secretive directions were in the same range (i.e., ~ 1.4x 10-5 cm/sec), indicating that 
no active transport mechanism in the corneal epithelium seems to be involved in the 
absorption of MOX. The observed Papp values were in the same order of magnitude 
compared to other substances with similar physicochemical properties (Table 2). 
 
Table 1: Papp values of moxaverine-hydrochloride across primary rabbit corneal 
epithelial cell layers (mean ± SD, n = 9) 
Papp (x10-5 cm/sec) + TEER (after experiment) Direction of drug 
transport + benzalkonium chloride/EDTA - benzalkonium chloride/EDTA 
Absorptive 
(a to b) 
1.28 ± 0.41 
TEER: 2203 ± 202 Ω * cm2 
1.38 ± 0.41 
TEER: 2288 ± 358 Ω * cm2 
Secretive 
(b to a) 
1.33 ± 0.22 
TEER: 2137 ± 311 Ω * cm2 
1.43 ± 0.94 
TEER: 1939 ± 640 Ω * cm2 
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Table 2: Comparison of Papp values (for details, see [27]) 
All Papp were examined for absorption (i.e., a to b direction) across rabbit cornea. 
Substance MW Log P pH Papp(x 10-5 cm/sec) 
Corynanthine 354 3.01 7.70 1.10 
4, 6-dichloroethoxzolamide 283 3.70 7.65 3.90 
Flurbiprofen 244 3.75 7.40 2.10 
Progesterone 314 3.78 7.65 2.00 
Progesterone 314 3.78 7.50 1.80 
Propranolol 259 2.75 7.50 3.10 
Penbutolol 291 4.04 7.00 2.20 
Moxaverine-HCl 344 4.02 7.40 1.38 
 
The preservative benzalkonium chloride/EDTA does not appear to alter MOX 
transport across primary cultured rabbit corneal epithelial cell layers. We note, 
however, that a decrease of ~23% in TEER values of the cell layers during the 
experiment was observed in the experiments carried out using the preservative 
containing buffer. This lowering of TEER may have occurred because of 
complexation of Ca2+ with EDTA, subsequently loosening tight junctions. It appears 
that such decrease in TEER does not result in an increased Papp of MOX, which is 
already high at baseline. 
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Discussion 
 
This study provides first evidence of the feasibility of a targeted delivery of 
moxaverine-hydrochloride to the posterior parts of the eye after topical instillation. 
Except for the cornea and conjunctiva, which were in close and direct contact with the 
applied drug solution, only low drug levels could be found in the anterior part, 
because of either low affinity to the tissue or the high turnover rate of 0.21 to 0.34 
ml/min/mm Hg for the aqueous humor [24]. This is indicative for low local side 
effects during topical dosing in clinical treatment of diseases of the posterior part of 
the eye. 
For the posterior part, comparably high amounts of MOX could be detected. 
Particularly for the compartment of interest, the retina, detectable drug amounts are a 
promising observation. Ocular dosing shows a fast accumulation of the drug, even 
increasing values throughout the experimental period. By contrast, systemic dosing 
leads to a decrease in the drug level during the same time period, resulting in part to 
high clearance rates of MOX from the systemic circulation [25]. For the human body, 
a high rate of metabolism was found (iphar 87/253 study). MOX is degraded to an 
aldehyde and an alcohol structure. The pharmacologic activity of these metabolites is 
unknown. The presence of metabolites in our study is most likely, but was not 
examined. 
For drug penetration, the following ways of distribution have been reported [26]: 
The direct corneal pathway, the conjunctival-scleral pathway, distribution by the local 
vasculature and the re-entry from general circulation after drug absorption. The 
contribution of the general circulation to the drugs penetration to posterior 
compartments in this case is very low, reflected by the low concentration values in the 
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plasma. The effect of the local vasculature has not been examined. Very likely is the 
diffusion by the conjunctival-scleral pathway, because it has been shown to be a way 
of diffusion for substances with high molecular weight. We have also shown that 
cornea is not a permeability barrier for the absorption of MOX into the eye. It is most 
likely that the drug is absorbed in this direct way. 
The significantly lower drug levels in plasma are worthy of particular note. 
Further studies are required to determine whether the detected drug levels can achieve 
the desired pharmacodynamic effect. 
 
The permeability data of MOX across the primary corneal epithelial cell model 
did not reveal any directionality, indicating that MOX has no affinity to transport 
proteins such as P-glycoprotein. Moreover, the Papp for MOX is in the range of 10-5 
cm/sec. Thus, the corneal epithelium may not be a critical barrier for the delivery of 
MOX. Addition of benzalkonium chloride/EDTA may have led to loosening of tight 
junctions of the cell layer, indicated by a decrease of the TEER values by the 
inclusion of benzalkonium. Despite the observed decrease in TEER, Papp of MOX 
across the cell layer was not affected significantly. Thus, we may conclude that 
absorption of MOX across the corneal epithelial barrier occurs mainly via 
transcellular passive diffusion. An enhancing effect of preservatives on absorption of 
hydrophilic drugs due to complexation of Ca2+ with EDTA by opening of tight 
junctions has been reported earlier [21,22]. 
In conclusion, we showed herein that a potentially new drug in ophthalmology, 
moxaverine-hydrochloride, reaches significant drug concentrations in posterior 
compartments of the eye after topical application and that absorption of this 
compound is not mediated by active transport processes. 
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Introduction 
Because animal testing is evaluated controversionally, other more accepted and easier 
methods have been established since cell culture started in the early 20th century [1, 2]. 
Major drawbacks for animal testing are the high maintenance costs and efforts. Scientifically, 
the complexity of the “test” system and the high variation of the outcomes are major points 
for criticism. Last, but not least does animal testing have a bad reputation and low acceptance 
in the modern Western society. Therefore, lots of efforts have been put into the development 
of cell culture systems that replace laboratory animals in scientific studies. 
For ocular tissues, two major aspects are of importance: ocular irritation and ocular drug 
penetration and delivery. 
A major tool for ocular irritation testing is the Draize test, developed in the 1940s by Draize et 
al. [3]. Briefly, in this test, laboratory rabbits are dosed ocularly with the test substance and 
changes on the dosed eye are observed and compared with the untreated rabbit eye over a 
predetermined time. 
For ocular drug delivery, in vivo studies on various animals have been a standard tool and are 
still performed today [4, 5, 6, 7]. 
To get an easier to handle tool, various ex vivo and in vitro cell models have been developed. 
Main advantages of these models are  
(1) Fixed conditions for the examination of cell growth, differentiation, and response to 
(chemical) agents 
(2) Easy access to the apical (i.e., front part) and basolateral (i.e., rear part) side of the 
cells or tissue 
(3) Absence of foreign cells from unwanted tissue 
(4) Quick and easy determination of data on drug transport processes on ocular irritation 
or damage 
(5) Reduction of animal experiments 
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A variety of corneal epithelial cell cultures have been established in recent years. Besides the 
immortalized cell culture models that have an extended life span, improved cell growth 
characteristics and are easy to handle [8], various attempts have been made to establish 
primary corneal epithelial cell cultures that better resemble the in vivo situation and have 
other than immortalized cell models not lost original cell properties [9]. 
Different techniques have been applied to generate these cell models: explantation techniques 
[10, 11], enzymatic treatments [12, 13] and mechanical processing [14, 15]. Successful 
primary cultures of the corneal epithelium have been generated for following species: rabbit 
[10, 12], cow [16], guinea pig [17], rat [18], mouse [31] and pig [30].  
In the explantation technique, corneal epithelial cells are gained by outgrowth from tissue 
pieces, which are placed epithelial side down in a tissue culture treated petri dish. By 
culturing these pieces in an appropriate medium in an incubator, epithelial cells will grow 
from the tissue onto the cell culture dish. Ebato et al. [11] found that the limbal cells show a 
better proliferation than cells from the central cornea since the limbus between cornea and 
sclera is the origin of corneal stem cells [19, 20]. The overgrowth of the epithelial cell layers 
by fibroblasts from the stroma is considered as a major drawback of this technique. Schneider 
has developed a method to avoid this overgrowth [21]. 
For the enzymatic method, a gamut of different proteolytic enzymes [12, 13, 22] has been 
used to dissociate the cells. Basis of this method is the lysis of the intercellular proteins and to 
loosen the cell connections, so that single cells of a specific type are yielded. 
The mechanical processing uses sheer forces and mincing steps to separate corneal cells. A 
variety of scissors, scalpels and microtomes have been used for this purpose [14, 23].  
 
Even tough several attempts have been undertaken; so far a successful set up of a human 
corneal epithelial cell model was not achieved. 
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In this study, we tried to set up such a model by modifying the techniques described so far and 
merging these with new findings made in recent years. 
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Materials and Methods 
Materials 
Collagenase type II, pronase, protease type XIV, trypsin, ethanol and DNase I were purchased 
from Sigma (Steinheim, Germany). Dispase II was from Roche Applied Sciences (Mannheim, 
Germany), MACS MicroBeads (coated with monoclonal mouse anti-human epithelial antigen 
antibody HEA-125/CD326)were from Miltenyi Biotec (Bergisch Gladbach, Germany). 
Scalpel blades (Bayha, model No. 1), surgical scissors and forceps were purchased from Stoss 
Medica (Saarbrücken, Germany). 
Rat tail collagen type I was from Cohesion (Palo Alto, CA, USA) and fibronectin was from 
BD Bioscience (Heidelberg, Germany). McIlwain tissue chopper was from The Mickle 
Laboratory Engineering Co. Ltd. (Gomshall, Surrey, Great Britain), Ultra Turrax rotor-stator 
homogenizer was from IKA (Staufen, Germany). 
Corneal rings were left-overs from successful transplantations and a generous gift from the 
Lions Corneabank, Homburg, Germany. Minimal Essential Medium (MEM) and Dulbecco’s 
Modified Eagle’s Medium (DMEM) were from Invitrogen (Niederaula, Germany). 
Pattex Blitz Matic cyanoacrylate glue was from Henkel, Düsseldorf, Germany. 
All other chemicals were of highest grade available commercially. 
 
Methods 
Protease/DNase technique 
A technique previously described by Chang et al. [12] has been slightly adapted for our 
purposes. Briefly, the corneal rings exposed to a 0.2% solution of protease type XIV for 45 
min at 37°C before gently scraping them off. Protease activity was stopped by adding 
supplemented minimum essential medium (S-MEM) containing 10% fetal bovine serum 
(FBS). The addition of excess proteins caused a quenching of enzymatic activity. The 
following removal of the medium completely disposed of the protease. 
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Cell aggregation was reduced by including 0.75 mg/mL DNase I in the same solution. 
Isolated cells were washed and purified further by passing them through a 40-µm cell strainer. 
The resulting corneal epithelial cells were seeded into 25 cm2 cell culture flasks precoated 
with a mixture of rat tail (type I) collagen (1.8 mg/cm2) and human fibronectin (0.6 mg/cm2). 
DMEM/F12, supplemented with penicillin (100 U/mL), streptomycin (100 µg/mL), 
gentamicin (50 µg/mL), insulin-transferrin-selenium premix (10 µg/mL ITS+, BD 
Biosciences, San Jose, CA), bovine pituitary extract (30 µg/mL), epidermal growth factor 
(EGF, 1 ng/mL) and hydrocortisone (0.36 µg/mL), was used as culture medium. Cells were 
maintained in a humidified incubator at 37°C in 5% CO2 atmosphere. Culture medium was 
changed every other day. Cell yield and growth were monitored microscopically 
 
 
Other enzymatic techniques 
All dissociation techniques were tested at 37°C and 4°C for 45 min. 
For enzymatic treatment of tissues the following enzymes have been described in literature: 
collagenase II [29], dispase II [30], pronase [22], and trypsin [22]. 
Tested concentrations were 1.2 U/mL dispase II, 167 U/mL collagenase II, 167 U/mL 
collagenase II with 9563 U/mL trypsin, 334 U/mL collagenase II with 19130 U/mL trypsin, in 
balanced salt solution (BSS; 137 mM NaCl, 5 mM KCl, 0.7 mM Na2HPO4, 10 mM HEPES, 
5.5 mM glucose, 1.8 mM CaCl2, 1.2 mM MgSO4, pH = 7.4), respectively. 
For cell isolation, the corneal rings were treated with the respective enzyme for 45 min either 
at 37°C or 4°C. After incubation corneal rings were attached to the outer bottom surface of 
glass centrifuge tubes with cyanoacrylate glue. Epithelial cells were then removed from the 
corneal surface by gentle scraping with a scalpel blade. Harvested cells were washed and 
purified by passing the solution through a 40-µm cell strainer. For pronase, collagenase II and 
collagenase II/trypsin, cell clotting was avoided by the use of 0.75 mg/mL DNase I in the first 
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washing step. Cells were seeded into 25 cm2 cell culture flasks and maintained with 
DMEM/F12, supplemented with penicillin (100 U/mL), streptomycin (100 µg/mL), 
gentamicin (50 µg/mL), ITS+ (10 µL/mL), bovine pituitary extract (30 µg/mL), EGF (1 
ng/mL) and hydrocortisone (0.36 µg/mL). Cell growth was monitored microscopically. 
For dispase II, the most commonly used enzyme for human tissue in literature, incubation 
times were altered from 45 min to 12 h, 16 h, and 24 h to increase cell yield. 
With dispase II also an alternative method was developed: after treatment of the corneal rings 
with the enzyme for 16 h at 4°C, corneal rings were washed twice with cold PBS and 
epithelial cell sheets were further loosened by a 1 min treatment with ethanol 20% at 37°C 
and subsequent scraping in PBS with a scalpel blade. Scraping and washing liquids were 
collected and centrifuged for 7 minutes at 1200 rpm (= g). Cells were washed with MEM with 
10% FCS and then seeded in cell culture flasks with supplemented DMEM/F12 (1:1) mix. 
For collagenase/trypsin different enzyme concentrations were tested to optimize the cell yield. 
 
 
Explantation technique 
The explanation technique was performed as previously described [11]. Briefly, sclera was 
removed from the corneal rings and 9 mm2 cornea pieces were cultured in fibronectin 
/collagen-coated Petri dishes with the epithelial side down. As cell culture medium served 3.5 
mL of DMEM/F12, supplemented with penicillin (100 U/mL), streptomycin (100 µg/mL), 
gentamicin (50 µg/mL), ITS+(10 µL/mL), bovine pituitary extract (30 µg/mL), EGF (1 
ng/mL) and hydrocortisone (0.36 µg/mL). 
After 3 weeks, the sprouted corneal epithelial cells were removed from the Petri dish by 
gentle scraping with forceps and scalpel blades. The harvested cell sheets were subcultured in 
collagen/fibronectin coated chamber slides to form confluent cell layers. 
48 
Chapter 2: Set-up of a primary human corneal epithelial model 
Mechanical methods 
Two mechanical isolation protocols were developed and combined with enzymatic treatment 
to increase cell yield: 
For the first method, the tissue was cut on a McIlwain tissue chopper and then the 5 µm slices 
were treated with trypsin/collagenase solution for 1 h at 37°C. Single cells were gained by 
washing and passing the cell/tissue pellet through a cell strainer. Cells were seeded and 
monitored as previously described. 
 
In a second protocol, tissues were grinded with an Ultra Turrax rotor-stator homogenizer after 
removal of scleral tissue, followed by either a 2 h treatment with dispase II at 37°C or an 18 h 
dispase II treatment at 4°C. Cells were then washed, passed through a cell strainer and seeded 
as already described. 
 
MACS MicroBead technique 
The target of the MicroBead technique was to improve the cell yield by means of a positive 
selection of epithelial cells. The theoretical procedure is shown in figure 1 and the 
experimental set-up for cell sorting in figure 2. 
Briefly, the tissue was cut on the McIlwain tissue chopper and treated enzymatically with a 
collagenase II/trypsin mixture at 37°C for 1 h or grinded with the UltraTurrax homogenizer 
and then treated with dispase II at 4°C for 18 h or at 37°C for 2 h, respectively. The cell 
suspension was washed with a solution of DNase I (0.75 mg/mL) in MEM with 10% FCS and 
then with MEM with 10% FCS alone. The suspension was passed through a 40-µm cell 
strainer. Cells were centrifuged and resuspended in 1.4 mL MEM with 10% FCS and 100 µL 
MACS MicroBead solution was added. The mixture was kept on an orbital shaker for 30 
minutes at 8 – 11°C. The magnetic beads are coated with specific epithelial antibodies  and 
bind to the human epithelial cells. Positive selection of epithelial cells on the supplied 
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magnetic column followed according to the manufacturer’s instructions. Selection was 
achieved by reconstitution of the column with 3 mL washing buffer (PBS supplemented with 
0.5% bovine serum albumin and 146 mM EDTA), followed by passing the cell/MicroBead 
solution through the column attached to its magnetic holder. The column was washed four 
times with BSS and the positively selected cells were removed from the detached column 
with 5 mL S-MEM with 10% FBS. The purification process was repeated with a second, 
unused magnetic column. Positively selected cells were washed from the column with 2 mL 
of supplemented DMEM/F12 medium per corneal ring used. 
 
 
 
 
 
 
 
Figure 1: Isolation steps for the positive selection of corneal epithelial cells. 
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Figure 2: MACS MicroBead column and magnetic holder 
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Results 
For all applied techniques, the outcome of experiments was very unsatisfactory. While the 
protease/DNase and the pronase treatment showed no effect on the corneal cell layers, results 
could be improved with an appropriate collagenase II/trypsin or dispase II treatment. The 
evaluation of the enzymatic treatments is summarized in table 1. 
 
Table 1: Summary of the results of the enzymatic treatment of human cornea 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 shows a representative microscopical image after enzymatic isolation of the 
epithelial cells. Cell number was in general very low. Seeding density was insufficient for the 
25 cm2 cell culture flasks as well as the smaller chamber slides. 
Attempts to further increase the cell yield by specific selection of epithelial cell species with 
magnetic beads did not alter the cell amount in the desired fashion. 
Explant techniques showed a higher success and yielded intact cell sheets. However, 
subcultivated cell sheets lacked sufficient proliferation activity and were unable to grow to 
confluent cell layers 
 
 
Used with rabbit cornea, but not suitable for human 
cornea (no cell yield)  
Cell gain unsatisfactory  Pronase 
Advantage: no cell clotting, very gentle 
BUT: small cell amount, alteration of incubation time up 
to 24 h did not increase efficacy
 
() Dispase 
187.5 µL/62.5 µL: too much cell damage 
93.75 µL/31.25 µL: good results, but small cell amount 
Trypsin/ 
Collagenase 
Only little amount of cells is gained () Collagenase 
 
Protease 
Comment Result Enzyme 
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Figure 3: Light micrograph of isolated cells from corneal epithelial cells 
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Discussion 
Even though enormous developments have been made in our understanding of cell culture and 
isolation procedures in recent years, we still encountered major problems while isolating cells 
from corneal tissue. 
Some of these problems are surely to be found in the physiology of the corneal tissue. In 
addition, the storage time of about 21 days, might contribute to the low activity of the 
epithelium. Albeit the transplantation efficacy stays unaffected, the corneal epithelium might 
be critically suppressed in its viability. 
As already mentioned in the introduction, the corneal epithelium consists of 9 layers that 
show different states of differentiation and keratinozation, with only the lowest, first layer 
consisting of basal cells with mitotic activity. This results in only 1/9th of the harvested cells 
having proliferating activity. So the number of useful cells is per se low. 
Secondly, the number of cell layers present in the corneal epithelium is highly variable and 
alters from specimen to specimen. We were able to show the high variance and a possible 
reduction of cell layers during storage by light micrographs using a standard hematoxyline 
staining (Figure 4). 
 
Normal human corneal epithelium Human corneal epithelium stored for 21 days 
 
 
 
Figure 4: Different thickness and reduction of cell layer number in human corneal rings 
(magnification 400x) 
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Many of the applied enzymes have been used with corneal tissue of different species. The 
spectrum ranges from amphibian (frog) to rodents (rabbits, rats) and mammals (pigs). Since 
inter-species differences are natural we can expect a diverse composition of the intercellular 
matrices, which results in different resistance levels to proteolytic enzymes. So it is not 
surprising to find that protease XIV works well with rabbit cornea [12] but does not affect 
human tissue. 
Even though the magnetic selection of epithelial cells proved very helpful in the isolation of 
other primary epithelial cells [24], this method did not improve the outcome in our 
experiments. Since a non-successful binding of the antibody-labeled beads to the epithelial 
cells can be ruled out, the low cell yield may be based on the following issues: 
The amount of available tissue is very low. The number of corneal rings per isolation is 
generally limited to about 4 tissues. The tissues consist of a corneal ring of about 5 mm 
diameter, which reduces the number of available cells quite significantly. 
The isolation procedure consists of a respectable amount of washing and purification steps 
that bear the risk of high cell losses. These losses are likely to have occurred in our protocol 
despite careful preparation. 
For the explantation techniques, it is known that corneal cells have a limited capacity of 
proliferation. The number of possible passages in culture is limited to 2 to 7, depending on the 
origin of the cells [13]. As separated epithelial sheets do not adhere very well to artificial cell 
culture surfaces, further obstacles have to be considered and offer a possible explanation for 
the unsuccessful cultivation activities. 
Another point is the selection of cell culture medium. A variety of cell culture media and 
supplements have been described in literature. Most of these media were tested on cell 
systems of animal origin. Many media contained fetal bovine serum as supplement [21, 25, 
26, 27], which is a standard additive and generally provides all nutrients and hormones 
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needed. A major drawback in this context is that serum is not present in, at or around corneal 
tissue under physiological conditions. 
Serum-free media was firstly described by Hackworth et al. [28] for the culture of porcine 
corneal epithelium and rabbit corneal epithelium. Chang et al. used a refined and very useful 
serum-free medium on primary rabbit corneal epithelial cell layers [12]. 
Since this medium proved very successful on these cells and did not contain unphysiological 
serum, it was chosen for our research. Unfortunately, due to our low cell yields, we were not 
able to control and optimize the composition of the chosen medium. 
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Abstract 
Purpose: To evaluate different corneal epithelial cell culture systems for ocular drug 
permeability in vitro studies. 
Methods: Transformed human corneal epithelial cells (HCE-T) and Statens Serum Institut 
rabbit cornea cells (SIRC) were cultured on permeable filters. Skinethic human corneal 
epithelium (S-HCE) and Clonetics human corneal epithelium (C-HCE) were received as 
ready-to-use systems. Excised rabbit (ERC) and human cornea (EHC), mounted in Ussing 
chambers, were used as references. Barrier properties were assessed by measurement of 
transepithelial electrical resistance and apparent permeability (Papp) of markers with different 
physico-chemical properties: fluoresceine-sodium, propranolol-hydrochloride, moxaverine-
hydrochloride, timolol-hydrogenmaleate, and rhodamine123. 
Results: SIRC cells and the S-HCE failed to develop barrier properties and hence, were 
unable to distinguish between the markers. Barrier function and power to differentiate 
permeabilities were found in HCE-T and even more pronounced in C-HCE. The latter 
corresponded very well with EHC and ERC. Net secretion of rhodamine123 was not observed 
in any model, suggesting that P-glycoprotein or similar efflux systems are unlikely to affect 
corneal permeability.  
Conclusion: Currently available corneal epithelial cell culture systems show differences in 
epithelial barrier function. Those systems lacking functional cell-cell contacts are of limited 
value for assessing corneal permeability, but may be useful for other purposes, such as 
irritancy tests. 
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Introduction 
The assessment of corneal penetration is crucial both for the development of ophthalmic 
medicines as for the safety evaluation of new materials. Until recently animal testing [1, 2, 3] 
has been the main option for such purposes, but an increasing number of in vitro models have 
already been suggested as potential alternatives[4-10]. Moreover, corneal constructs have 
been set-up, containing epithelial, stroma- and endothelial equivalents to mimic the whole 
cornea [11, 12]. However, a comparative evaluation of the currently available models has not 
yet been performed.  
The reduction of animal experiments by such in vitro models is in accordance with the 3 R 
principles, firstly introduced by Russell and Burch in 1959 [13]. The 3 R’s stand for Replace, 
Reduce and Refine and are guidelines for the application of animal experiments in scientific 
research. For the sake of animal welfare, cost reduction and a wish for enhanced 
reproducibility of experimental data, replacement of animal experiments by suitable in vitro 
test systems has become important issue. 
 
Skinethic reconstituted human coreal epithelium (S.HCE, Skinethic), transformed human 
corneal epithelial cells from Araki-Sasaki’s lab (HCE-T) [5], Statens Serum Institut rabbit 
cornea (SIRC) [9], and Clonetics human corneal epithelium (C-HCE, Cambrex) were selected 
for testing and comparison versus excised (native) human and rabbit cornea. The already 
mentioned corneal constructs represent very complex systems, truly mimicking the in vivo 
situation. A drawback of these systems is the complexity. Due to their three-layer-setup they 
are difficult to produce and take quite a long time to grow, which makes them only frequently 
available. Thus, we did not include these models. Still, the epithelial cell line used by Zorn-
Kruppa et al [12] was the HCE-T cell line, which is included in our portfolio. The CEPI 17 
CL4 cell line used by Reichl et al [11] is tightly regulated by its manufacturer and so 
unavailable for broad usage. 
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To evaluate the potential of these models to distinguish between drugs with respect to their 
corneal permeability, the transepithelial electrical resistance (TEER) was routinely measured 
to obtain an estimate of epithelial barrier function. Complementary histological data at light 
microscopy level were also obtained for all in vitro model tested. Subsequently, the following 
compounds with different physico-chemical properties were selected for transport 
experiments: fluorescein-sodium as a hydrophilic low permeability marker; propranolol-HCl 
as a lipophilic high permeability marker, rhodamine 123 as a substrate of P-glycoprotein to 
detect the possible activity of such efflux transporters. Additionally, we examined timolol-
hydrogenmaleate and moxaverine-HCl as two drugs of ophthalmologic relevance [14]. 
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Materials and Methods 
Chemicals 
Fluorescein-sodium (FluNa), rhodamine 123 (Rh123), formaldehyde and ethanol were 
obtained from Sigma (Seelze, Germany). Cyclosporine A (CyA) and penicillin/streptomycin 
were purchased from Calbiochem (Darmstadt, Germany). Propranolol-hydrochloride (Prop) 
was from Synopharm (Barsbüttel, Germany). Timolol-hydrogenmaleate (Tim) was a generous 
gift from Ursapharm Arzneimittel (Saarbrücken, Germany). 14C-moxaverine-hydrochloride 
(Mox) was purchased from Biotrend (Cologne, Germany). Permeable filter inserts (Transwell 
3460) were from Corning (Bodenheim, Germany). Eosin G 0.5% solution, Mayer’s 
hematoxylin solution, xylene, Paraplast paraffin beads and Roti-Histokitt mounting reagent 
were from Carl Roth (Karlsruhe, Germany). All other chemicals were of highest 
commercially available grade. 
 
Cell culture systems and tissues 
Statens Serum Institut rabbit corneal (SIRC) epithelial cells: The SIRC cell line (ATCC CCl-
60) was derived from the cornea of a normal rabbit in 1957 by Volkert at the Statens Serum 
Institut (Copenhagen, Denmark). Little is recorded relating to the history of this cell line for 
approximately the first 400 passages. It was originally used for the cultivation of rubella 
viruses. In 1990, the cells were morphologically characterized by Niederkorn and co-workers 
[15]. The cells do not exhibit an epithelial, cobblestone-like morphology, but a fibroblast 
phenotype. Cells were cultured in minimum essential medium (MEM) with 10% FBS, 100 
µg/ml streptomycin and 100 U/ml penicillin G. To stimulate growth, the cell culture medium 
was altered according to Hutak et al [9]. 
 
HCE-T cells (HCE-T): The HCE-T cell line was established in 1995 by Araki-Sasaki and co-
workers [5]. It was gained by transfection of human corneal epithelial cells from a 47-year old 
66 
Chapter 3: Comparison of corneal epithelial cell culture models 
female donor with a recombinant SV40-adenovirus.HCE-T cells were purchased from Riken 
Cell Bank (RCB1384, Ibaraki, Japan) and cultured on Transwell filter inserts at a seeding 
density of 60,000 cells/cm2 in DMEM/Ham’s F12 1:1 mixture supplemented with 5% FBS, 5 
µg/mL insulin, 0.1 mg/mL cholera toxin, 10 ng/mL EGF, 0.5% DMSO, 100 µg/ml 
streptomycin and 100 U/ml penicillin G. Cells of passage numbers 75 to 84 were used. A 
modified protocol according to Toropainen and co-workers [16] was used. In brief, cells were 
maintained for 1 week under liquid covered conditions and were then switched to air-
interfaced condition in the second week. Medium was changed every other day during the 
first week and daily in the second week.  
 
Skinethic reconstituted human corneal epithelium (S-HCE): Reconstituted human corneal 
epithelium was purchased from Skinethic (RHC/S/5, Nice, France). The model consists of 
human corneal epithelial cells immortalized by Beuerman at the Louisiana State University 
Eye Center (New Orleans, USA). S-HCE cells are routinely cultured by the manufacturer on 
NUNC filter inserts (CC-Inserts, 137052) and shipped to the end user at day 5 after seeding. 
Upon arrival, cells were transferred from the transport medium to the culture medium 
supplied by Skinethic. S-HCE were used within 24 hours of their arrival. 
 
Clonetics cultured corneal epithelium (C-HCE): C-HCE were purchased from Cambrex 
(CMS-2015, Vervier, Belgium). The model is made from normal human corneal tissue. 
Epithelial cells were isolated and infected with an amphotropic recombinant retrovirus 
containing HPV-16 E6/E7 genes to extend the lifespan. The cells (age: day 20) arrived in 
Transwell filter inserts (3470) and were transferred to the provided medium upon arrival. C-
HCE were used within 24 hours of their arrival. 
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Excised rabbit cornea: Rabbit corneas from animals to be slaughtered for food produce were 
bought from local breeders. No animals were sacrificed exclusively for our experiments. Eyes 
from pigmented purebred rabbits were enucleated directly after slaughtering. After removing 
adhering tissue, the cornea was obtained by cutting the scleral tissue in about 2 mm distance 
to the limbus between cornea and sclera. The cornea was cleaned by washing with PBS and 
then stored in cell culture medium (DMEM/F12 Ham 1:1 mix with 100 µg/ml streptomycin , 
100 U/mL penicillin G, 100 µg/mL, insulin-transferrin-selenium premix, 30 µg/mL bovine 
pituitary extract , 1 ng/mL epidermal growth factor, 0.36 µg/mL hydrocortisone) until use.  
 
Excised human cornea: Corneas considered not suitable for transplantation due to their low 
density of endothelial cells were donated by the Lions Cornea Bank (Homburg, Germany) and 
served as reference. Since the main permeability barrier of the cornea is represented by the 
corneal epithelium and the contribution of stroma and endothelium to the barrier properties of 
the cornea is neglectable [17, 18], this appeared to be acceptable for our purposes.  
 
All cells and tissues were kept in an incubator at 37°C, 5% CO2, 90% rH until use. 
 
Histology 
Filter-grown tissue samples were fixed in a formaldehyde solution (4% in PBS) at room 
temperature for 30 min. HCE-T and C-HCE samples were stained with hematoxylin for about 
20 min. Four to 5 steps of washing with water stopped the staining process. Samples were 
then dehydrated through a graded series of ethanol at 70%, 96%, and 100% at room 
temperature and kept in xylene until embedding. For mounting, samples were soaked in 
paraffin wax at 60°C overnight and embedded the next day. Embedded samples were cut in 
four-micrometer thin sections with a microtome (Leica Microsystems, Nussloch, Germany) 
and mounted on glass slides at room temperature. Samples of human cornea and rabbit cornea 
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were counter-stained with Eosin G for 30 s and washed with ethanol of 96% and 100%. 
Samples were dewaxed with xylene and were rehydrated by a graded series of ethanol at 
100%, 96%, and 70%, for 10 min each, at room temperature. The sections were washed with 
de-ionized water and staining was intensified by a 5 min treatment with Mayer’s hematoxylin 
solution. Sections were stored in xylene until mounting using Roti-Histokitt. The sections 
were examined with an Axiovert 40 light microscope (Carl Zeiss, Jena, Germany) at 400x 
magnification. 
For immunofluorescence staining of the nucleus, specimens were fixed with 2% 
paraformaldehyde (10 min) and subsequently blocked for 10 min in NH4Cl solution (50 mM), 
followed by permeabilization for 15 min with 0.1% Triton X-100. Propidium iodide (1 µg/ml) 
was used to stain cell nuclei. After 30 min of incubation, the specimens were washed three 
times with PBS and embedded in FluorSafe anti-fade medium. Images were obtained by a 
confocal laser scanning microscope (MRC-1024, Bio-Rad, Hemel Hempstead, UK) with the 
instrument settings adjusted so that no positive signal was observed in the channel 
corresponding to green fluorescence of the isotypic control and the focus pane at the level of 
the nuclei of the topmost cell layer. 
 
Transepithelial electrical resistance 
To monitor the formation and functional integrity of cell layers the transepithelial electrical 
resistance (TEER) was measured with and epithelial voltohmmeter equipped with STX-2 
“chopstick” electrodes (EVOM, World Precision Instruments, Berlin, Germany) and corrected 
for the background provided by the blank filter. Only cell layers with TEER values >400 
Ω·cm2 were used for the transport experiments. This value is generally accepted as the 
minimum requirement for tight barrier properties [19].  
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Transport studies 
Transport of marker compounds was studied at the following concentrations: FluNa: 50 µM; 
Prop: 50 µM; Rh123; 13 µM; Tim 200 µM; Mox 33 µM = 1µCi/mL). Data are presented as 
mean ± standard deviation (n), where n is the number of observations.  
 
For transport studies the cell layers were equilibrated for 1 h in modified Krebs Ringer buffer 
(KRB, 1.5 mM K2HPO4, 3 mM KCl, 4 mM glucose, 142 mM NaCl, 10.07 mM HEPES, 1.4 
mM CaCl2, and 2.56 mM MgCl2, pH 7.4). The transport experiments were initiated by 
exchanging KRB of the respective donor side with the same volume of KRB containing the 
respective drug. The apical and basolateral volumes were 520 µL and 1520 µL (HCE-T) and 
210 µL and 810 µL (S-HCE and C-HCE), respectively. To determine the initial concentration, 
10 µL (S-HCE, C-HCE) and 20 µL (HCE-T) samples of the donor solution were assayed. 
Samples were drawn from the corresponding receiver compartment every 30 min for up to 4 
h. Sampled volumes, i.e.,200 µL,(HCE-T) and 100 µL (S-HCE and C-HCE) were replaced by 
the same amount of fresh pre-warmed KRB. Transport of Rh123 was also determined in the 
presence of 10 µM CyA to determine the possible inhibitory efficacy on Rh123 transport. 
 
Corneal tissues, either human or rabbit, were mounted in a modified Ussing chamber (round 
opening, 10 mm diameter) [20] and equilibrated with KRB for 1 h prior to the transport 
experiments. Flux studies were initiated by exchanging the KRB of the respective donor side 
with a same volume of marker solution. The volumes in the mucosal and serosal chamber 
were 2.5 mL each. Samples (200 µL) were drawn from the receiver compartment every 30 
min for up to 4 h. Sampled volumes were replaced by the same amount of fresh pre-warmed 
KRB. To determine the initial donor concentration, 20 µL samples of the donor solution were 
assayed.  
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Sample analysis 
For FluNa and Rh123, fluorescence activity of samples was analyzed in 96-well plates using a 
plate reader (Cytofluor II, PerSeptive Biosystems, Wiesbaden, Germany) at excitation and 
emission wavelengths of 485 and 530 nm, respectively.  
For Prop and Tim, concentrations were determined by HPLC on a Summit system comprised 
of a P580 pump, ASI100 automated sampler, and UVD170S UV/VIS detector (Dionex, 
Idstein, Germany). A LiChroCART 125-4 LiChrosphere 100 RP-18 (5 µm) column was used 
and the samples were analyzed at 215 nm (Prop) or 297 nm (Tim), respectively. A mixture of 
acetonitile:methanol:water 22:33:45 with 330 µL triethylamine and 440 µL phosphoric acid 
served as mobile phase at a flow rate of 1.2 mL/min. Chromatograms were analyzed by 
estimating the area under the peak employing a computerized data integration program 
(Chromeleon 6.50, Dionex). Samples were diluted with KRB, where appropriate. 
Mox was assayed with a liquid scintillation counter (Perkin Elmer, Rodgau, Germany) after 
mixing the samples with 4 mL Ultima Gold scintillation cocktail (Perkin Elmer). 
 
The apparent permeability of the marker substances was calculated as  
Ac
JPapp
*0
=   (Eq. 1) 
where J = marker flux (mol/s), c0 = initial marker concentration in the donor solution 
(mol/cm3) and A = surface area of the corneal tissue and cell layers. The latter was 1.27 cm2 
for intact tissues, 1.13 cm² for HCE-T cell layers, 0.5 cm² for S-HCE, and 0.33 cm² for the C-
HCE. 
To quantify the power of the different models to distinguish between high and low 
permeability compounds, we calculated the high-low (h/l)-ratio, 
)(
)(Pr
/
FluNaP
opP
ratiolh
app
app
=  (Eq. 2) 
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Moreover, the permeability of all markers was compared for each model by calculating 
relative Papp values as a percentage of the high permeability marker propranolol. 
72 
Chapter 3: Comparison of corneal epithelial cell culture models 
Results 
Histology  
While excised human cornea and excised rabbit cornea are composed of all corneal cell 
layers, i.e., epithelium, stroma, and endothelium (Figure 1 A&B), the cell lines obviously 
consist only of epithelial cells (Figure 1 C-F). Apart from some differences in the size and 
shape of individual cells, most striking differences were found in the number and total 
thickness of the epithelial cell layers of the investgated models. Human cornea shows 4 to 5 
epithelial layers, while we found a thicker epithelium for the rabbit cornea and a denser 
stroma. 
 
While a progress in differentiation from basal cells to superficial cells can be clearly seen in 
excised human cornea, HCE-T cells (on day 14) maintain their cobblestone like appearance 
across all layers of a multilayer of 4-6 cells in thickness (Figure 1 C). CLSM images of 
propidium iodide-stained human cornea and HCE-T specimens underpin the difference in cell 
density and morphology when focused at the topmost cell layer (Figure 2 A&B). HCE-T cells 
grow to cuboidal-shaped cells at a very high density (Figure 2 B), while epithelial cells of the 
human cornea appear wider spread in shape (Figure 2 A). 
 
The SIRC cell line has formed 4 cell layers on day 21. The fibroblast-like phenotype can be 
recognized in Figure 1 D. The difference in morphology is in accordance with the missing 
barrier properties, as shown by TEER measurements(see below).  
 
The C-HCE model resembles the morphology of the rabbit tissue with a higher number of cell 
layers than the human counterpart (Figure 1 E). The epithelial cells exhibit various states of 
differentiation with cuboidal cells in the lower layers and cells of flattened appearance at the 
topmost aspect.  
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A) Excised human cornea B) Excised rabbit cornea 
 
 
 
C) HCE-T cells D) SIRC cells 
 
 
 
E) Clonetics human corneal 
epithelium  
F) Skinethic human corneal epithelium * 
 
 
 
 
 
 
Figure 1. Histological examination of the different in vitro models by hemotoxylin-eosin 
staining. A) Excised human cornea; B) excised rabbit cornea; C) HCE-T cells; D) SIRC cells; 
E) Clonetics human corneal epithelium (C-CHE); F) Skinethic human corneal epithelium (S-
CHE). Magnification 400x. * = Picture provided by Skinethic, France. 
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A) Human corneal tissue B) HCE-T cell layers 
  
 
Figure 2. Confocal laser scanning microscopy of A) and human corneal tissue and B) HCE-T 
cell layers. Images were obtained by focusing on the topmost cell layer  Scale bars represent 
micrometers. 
 
Multiple cell layers can also be observed in the S-HCE model (Figure 1 F). Seven to 10 layers 
in thickness, the S-HCE cells are of cuboidal shape and only the most apical layer contains a 
number of cells with flattened morphology. Nevertheless, the S-HCE cell model does not 
show a clear differentiation of the cells with progressing layer number. Compared to the other 
cell systems, the number of layers is the highest, however the cells do not form tight 
junctions, as found by TEER measurements (see below). 
 
TEER and permeability of transport markers  
Formation of electrically tight cell layers is probably most important feature of an in vitro 
model of drug absorption. Therefore, TEER values were recorded for all models under 
investigation. In case of the in house grown cell lines, TEER was measured every time the 
medium was changed. The excised tissues and commercially available models were assessed 
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upon their arrival. The permeability of all marker compounds as well as typically observed 
TEER values for each of the tested models are summarized in Table 1. 
 
Table 1: Permeability values (Papp) of marker compounds across in vitro models of corneal 
epithelium and transepithelial resistance (TEER) of those models. All values are mean ± SD 
with n≥3 
 
Papp (×10-6 cm/s) 
FluNa Prop Tim Mox Model 
AB BA AB BA AB BA AB BA 
TEER  
± SD 
(Ω*cm2) 
EHC 0.37 
± 0.26 
0.57 
± 0.19 
12.40 
± 2.65 
8.24 
± 1.13 
3.15 
± 1.03 
2.50 
± 1.02 
5.42 
± 1.97 
3.76 
± 1.54 
478 
± 355 
ERC 0.12 
± 0.03 
0.14 
± 0.04 
5.63 
± 2.81 
3.25 
± 1.01 
3.52 
± 0.71 
2.06 
± 0.50 
5.16 
± 0.11 
2.39 
± 0.71 
848 
± 553 
HCE-T 2.37 
± 0.29 
2.29 
± 0.09 
22.88 
± 5.33 
14.99 
± 1.59 
10.85 
± 1.91 
9.03 
± 0.17 
13.42 
± 0.83 
17.49 
± 2.36 
474 
± 120 
S-HCE 6.96 
± 0.55 
7.70 
± 0.53 
14.78 
± 1.72 
28.32 
± 3.19 
9.10 
± 1.07 
12.63 
± 0.32 
15.49 
± 1.33 
26.28 
± 3.10 
106 
± 15 
C-HCE 0.25 
± 0.10 
0.32 
± 0.10 
8.29 
± 0.20 
7.36 
± 0.85 
2.81 
± 0.40 
1.65 
± 0.36 
5.84 
± 0.27 
6.82 
± 2.24 
832 
± 365 
 
Intact cornea, either human (EHC) or rabbit (ERC), which may be supposed to represent the 
most complete barrier showed clear differences in Papp values for the marker compounds. The 
lipophilic high permeability marker Prop showed Papp values in the range of 10-5 cm/s. Such 
values were reported earlier for other cell systems [19, 21, 22] and are thus in the range that is 
expected. In contrast, the hydrophilic marker FluNa showed low permeability, as indicated by 
a low Papp value in the range of 0.3x10-6 cm/s. Such values have also been reported earlier [6, 
16]. A higher permeability than for FluNa was found for Tim and an almost equally high 
permeability as for Prop was found for Mox, corroborating the excellent ocular penetration of 
this compound in vivo, as was reported earlier14. Compared to EHC, ERC yielded the same 
ranking for the different Papp values which, however, were still approximately one magnitude 
lower than for EHC. 
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While SIRC cells did proliferate when cultured on permeable Transwell filters, the TEER 
remained at a level of the blank filter inserts (data not shown), suggesting that the cells did not 
develop tight junctions. As this could not be achieved by various alterations of the cell culture 
conditions, SIRC cells were not further considered for transport experiments 
 
A low TEER of 100 Ω*cm2 was measured for the pre-grown cell layers of the Skinethic 
model. Nevertheless performed transport experiments yielded comparatively high Papp values 
even for the low permeability marker FluNa. 
 
HCE-T cells formed tight cell layers, as indicated by a TEER of 500 Ω*cm2 and thus proved 
suitable for drug transport studies. Papp values were in the same magnitude as for EHC, but 
yielding results approximately twice as high as for EHC. Especially for the lipophilic markers, 
the power of differentiation was less than in EHC. Nevertheless, ranking of the substances 
with HCE-T was in accordance with the ranking found in EHC. 
 
C-HCE cell layers were received as tight epithelium and correlated well to the values found 
for EHC. Not only the hydrophilic markers were found at identical Papp values of about 2x10-7 
cm/s, but also the lipophilic markers were ranked identically in the range of 10-5 cm/s. Thus, 
correlation of this cell culture system to the intact human tissue (ex vivo) in terms of marker 
transport was very good. 
 
P-glycoprotein-mediated efflux 
Permeability of Rh123, a known substrate of P-glycoprotein, was assessed in both apical-to-
basolateral (AB) and basolateral-to-apical (BA) direction. A BA/AB ratio of 2 or was not 
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observed in any of the in vitro models (Table 2). Moreover, addition of the P-gp inhibitor 
cyclosporine A (CyA) did not alter fluxes.  
 
Table 2: Bi-directional transport of the P-glycoprotein substrate rhodamine 123 (Rh123) 
across various in vitro models od corneal epithelium. Experiments were conducted with or 
without presence of the P-glycoprotein inhibitor cyclosporine A (CyA). Values are mean ± SD 
with n≥3 
 
Papp (×10-6 cm/s) 
Rh123 Rh123 + CyA Model 
AB BA AB BA 
EHC 0.48 ± 0.48 0.59 ± 0.55 1.93 ± 1.37 1.16 ± 0.91 
ERC 0.15 ± 0.09 0.26 ± 0.24 0.03 ± 0.02 0.06 ± 0.02 
HCE-T 1.46 ± 0.42 2.25 ± 0.29 2.88 ± 0.11 4.39 ± 0.66 
S-HCE 4.84 ± 0.37 6.42 ± 0.12 4.76 ± 0.24 5.70 ± 0.19 
C-HCE 0.13 ± 0.01 0.26 ± 0.03 0.29 ± 0.05 0.22 ± 0.10 
 
Power of differentiation 
To compare the power of the various in vitro systems to differentiate between drug 
candidates, the ratio of Papp values for high and low permeability markers was calculated 
(Figure 3). In addition, the Papp values of the four permeability markers were normalized for 
each model as percentage of the permeability of the most permeable compound, Prop (Figure 
4). The rank order of fluxes was Prop>Mox>Tim>FluNa, which is in agreement with 
decreasing lipophilicity. Significant difference between the models can be observed in the 
standard deviations of the normalized permeability ratios, as well as in the range between the 
highest (Papp (Prop) = 100% by definition) and lowest relative permeability (Papp (FluNa) 
between >60% and <5% of Papp (Prop)).  
 
With an h/l ratio of nearly 40, EHC showed a good power of differentiation between the low 
and high permeability markers (Figure 3). The range of relative permeabilities spans from 
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100% to <5% with mostly non-overlapping standard deviations (Figure 4). For ERC, the h/l-
ratio even exceeded the value for EHC. With an h/l-ratio of about 10, as well as a range of 
relative permeabilities between 100 and approx 15%, the HCE-T model clearly demonstrates 
a higher ability to differentiate compared to the S-CHE model. As can be seen from Figure 3, 
S-HCE had an h/l ratio of approx. 1, similar to cell-free filter membranes. The C-HCE model 
showed an h/l-ratio being the same as for the human cornea, but with by far the smallest 
standard deviations and broadest range for the relative Papp values.  
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Figure 3. Power of differentiation in marker permeability for the different in vitro models as 
expressed by calculating the respective high/low (h/l)-ratios (= PappProp/PappFluNa). Data 
repesents mean ± SD, n = 3 
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Figure 4. Relative permeabilities of passive diffusion markers across the different in vitro 
systems. Values are shown as percentage of Papp Prop for each model, respectively. Error 
bars reflect the standard deviation by taking into account error propagation (i.e., summation 
of relative SD for both markers.) 
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Discussion 
In the presented work, we compared the currently available cell culture systems of corneal 
epithelium in their performance to assess permeability of xenobiotics. These models may help 
to reduce and replace animal experiments, by keeping handling and costs at a minimum, while 
providing robustness and good reproducibility. Still, the question arises, if such simple 
systems have sufficient power to differentiate and can be used as replacement for more 
complex ex vivo tissue from animals. Major progress was made in the replacement of the 
Draize test, hence, most of the available models are geared at this purpose, and barrier 
properties are typically not an issue. In this study, we used histology, bi-directional transport 
studies of passively transported drugs as well as P-gp substrates and the power of 
differentiation as tools to evaluate the models examined herein. 
Due to inter-species differences excised rabbit cornea did not resemble the human cornea too 
closely. Morphological differences were obvious: the stroma seems to be of higher density 
and contains more keratinocytes and the epithelial cells grew to more layers than in the human 
tissue. These anatomical differences can be the cause for low fluxes of the low-permeability 
markers. 
 
Two of the systems, the SIRC cell line and the S-HCE model disqualified at an early stage of 
the testing. Major drawbacks of these systems were the absence of tight cell layers.  
Of the remaining models, the HCE-T cell line has been used in several published studies16, 23. 
HCE-T cells form a tight multi-layered epithelium with the ability to distinguish several 
marker substances, although the calculated Papp values were slightly higher than across human 
corneal tissue. However, drawbacks of the HCE-T model are found in histology; as HCE-T is 
an immortalized cell line, differentiation does not occur as completely as in human corneal 
epithelium. We noticed these differences by examining the cell lines by light microscopy / 
CLSM and comparing the pictures with EHC micrographs. HCE-T do not form completely 
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differentiated superficial cells, but maintains their cobblestone-like appearance to a certain 
degree. In addition, we previously reported on differences regarding efflux transporters which 
make this cell model rather unsuitable for drug permeation studies (Becker et al., J Ocul 
Pharmacol Ther, in submission).  
The C-HCE model provides tight cell layers with TEER values > 400 Ω·cm² and therefore 
appears as a useful model for permeation studies. The absolute Papp values of the marker 
compounds corresponded well with excised human cornea, while the reproducibility appeared 
to be even better. Together with the high power of differentiation these results make C-CHE a 
valuable model for in vitro permeability testing. 
 
For reduction and replacement of animal experiments and refinement of methods, several in 
vitro models are available. Many are suitable as replacements for the Draize test. Of the 
models investigated in our study, C-CHE could be able to (at least partly) replace animal 
experiments to assess tissue distribution and penetration behavior of drug candidates. 
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Abstract 
Purpose: To compare expression profiles of P-glycoprotein (P-gp/MDR1), multi-drug 
resistance-associated protein 1 (MRP1), multi-drug resistance-associated protein 2 
(MRP2), lung resistance-related protein (LRP), and breast cancer resistance protein 
(BCRP) in human cornea and the cell line, HCE-T. 
Methods: Functional evidence for transporter activity was gathered by bi-directional 
flux studies across excised human cornea and HCE-T cell layers using rhodamine 123 
(Rh123). Moreover, human cornea and HCE-T cells were examined for mRNA and 
protein expression of P-gp/MDR1, MRP1, MRP2, LRP, and BCRP, using RT-PCR 
and immunofluorescence microscopy.  
Results: Flux studies of Rh123 revealed a slight but not significant (p < 0.05) 
asymmetry in transport across human corneas and HCE-T layers. Addition of 
cyclosporine A did not alter fluxes. Of all ABC-transporters under investigation, only 
LRP was found in human cornea. HCE-T cells did not show any signal for LRP, 
while expression of MRP1, MRP2, and BCRP could be confirmed. P-glycoprotein 
was not detected in any specimen under examination. 
Conclusions: Human cornea expresses a very limited array of ABC-transporters. The 
expression pattern of HCE-T cells, however, differs from the native corneal tissue. 
Hence, this in vitro model should be used with caution to predict in vivo transport 
properties across the corneal epithelial barrier. 
 
Keywords 
Multi-drug resistance, ocular drug absorption, transport proteins, RT-PCR, in vitro 
models 
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Introduction 
Topical eye medications are applied to the cul-de-sac of the eye, thus major emphasis 
of drug distribution and penetration is on the conjunctival-scleral pathway and the 
cornea. While the conjunctival-scleral pathway seems to be reserved for certain 
molecules of high molecular weight [1], the main transport pathway for the majority 
of drugs is represented by the cornea. The cornea consists of 3 regions with different 
physico-chemical properties: the 9 layers of the epithelium, which reflect the main 
barrier for drug penetration; the stroma; and an endothelial barrier. It has been found 
that only the epithelial cells exhibit tight junctions and adhere to each other via 
desmosomes [2], giving them important barrier properties. Stroma and endothelium 
on the other hand offer very little resistance to transcorneal permeation [3, 4]. The 
main function of the endothelium is to mediate ion and fluid transport and preserve 
the corneal transparency. The importance of the cornea as a penetration barrier raises 
the question of the presence of efflux transporter proteins as defense mechanisms, as 
well as obstacles for lipophilic drug penetration.  
The proteins of the ABC (ATP-binding cassette) family have been recognized to limit 
the absorption of drugs across mucosal barriers and other tissues, such as the 
endothelium of the blood-brain barrier [5, 6]. The ABC-superfamily of transporter 
proteins represents mostly transmembranic moieties that promote efflux of 
xenobiotics and thus reduce their intracellular accumulation. Substrate binding is 
unspecific and covers a wide spectrum of substances [7]. Overexpression of these 
proteins has been found after continuous administration of substances to tumors, as 
well as healthy tissues, which earned these proteins the name “multi-drug resistance” 
(MDR) proteins. Since the cornea provides a major route for the drug penetration into 
the eye [8], it is likely that protective mechanisms are functionally expressed in the 
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cornea. However, information on the expression patterns of these ABC-transporters in 
human ocular tissues is scarce. 
A variety of in vitro models based on excised tissues and epithelial cell cultures have 
been developed and refined for drug absorption/disposition studies over the last two 
decades. In this context, considerable attention has been given not only to the gastro-
intestinal tract, but also to the development of in vitro models of ocular epithelial 
barriers [8 - 13, 26]. These efforts resulted in a number of continuous cell lines and 
cells in primary culture, which are now available to mechanistically study drug 
absorption across the ocular mucosa in a controlled environment. The human corneal 
epithelial cell line, HCE-T, is among these models. HCE-T cells were generated in 
1995 by Araki-Sasaki and co-workers by immortalization of normal corneal epithelial 
cells from a 47-year old female donor using the SV40 virus [9]. HCE-T cell layers 
have been previously used as in vitro models for drug absorption experiments and 
toxicity testing [14, 15]. However, no data has been published on the array of 
transport proteins expressed by HCE-T to date.  
In this study, transport experiments across whole excised human cornea and HCE-T 
cell layers were carried out to functionally confirm and compare the corneal 
expression of P-glycoprotein (P-gp/MDR1) using the substrate, rhodamine 123 
(Rh123), and the inhibitor, cyclosporine A. Furthermore, excised human cornea and 
HCE-T cells were compared regarding the expression pattern of P-gp/MDR1, multi-
drug resistance-associated protein 1 (MRP1), multi-drug resistance-associated protein 
2 (MRP2), lung resistance-related protein (LRP), and breast cancer resistance protein 
(BCRP) at mRNA and protein level, using reverse transcription-polymerase chain 
reaction (RT-PCR) and immunofluorescence microscopy (IFM), respectively. In 
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addition, the morphology of the models in our hands was compared by light and 
confocal laser scanning microscopy (CLSM). 
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Materials and Methods 
Materials 
Cyclosporine A and penicillin/streptomycin were purchased from Calbiochem 
(Darmstadt, Germany). Rhodamine 123, mouse anti-P-gp antibody (clone F4), cholera 
toxin, bovine insulin, dimethyl sulfoxide (DMSO), formaldehyde and ethanol were 
from Sigma (Steinheim, Germany). Mouse anti-MRP1 antibody (clone MRPm6), 
mouse anti-MRP2 antibody (clone M2 III-6), and mouse anti-BCRP antibody (clone 
BXP-21) were all purchased from Chemicon (Temecula, CA, USA). Rat anti-LRP 
antibody (clone LMR5) was from Alexis (San Diego, CA, USA), MDR primers were 
manufactured by MWG Biotech (Munich, Germany) with the sequences shown in 
Table 1. RNA isolation, reverse transcription and PCR were performed using an 
RNeasy Mini kit, Omniscript RT kit and Taq PCR Master Mix kit, all from Qiagen 
(Hilden, Germany). Permeable filter inserts (Transwell Clear, 12 mm diameter, pore 
size 0.4 µm) were from Corning (Bodenheim, Germany). Eosin G 0.5% solution, 
Mayer’s hematoxylin solution, xylole, Paraplast paraffin beads and Roti-Histokitt 
mounting reagent were from Carl Roth GmbH & Co KG (Karlsruhe, Germany). All 
other substances used were of highest commercially available grade. 
 
Tissue preparation and cell culture 
Excised human cornea: Human corneas, unsuitable for transplantation due to their 
low density of endothelial cells, and leftover corneal rings from successful 
transplantations were a gift from the Lions Corneabank (University Hospital, 
Homburg, Germany).  
HCE-T cells: HCE-T cells were purchased from Riken Cell Bank (Tsukuba, Japan). 
HCE-T cells (passage numbers 75 to 84) were cultured on Transwell Clear filter 
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inserts at a seeding density of 60,000 cells/cm2. The culture medium consisted of 
Dulbecco’s modified Eagle’s Medium (DMEM)/Ham’s F12 (1:1 mixture) 
supplemented with 5% fetal bovine serum (FBS), 5 µg/ml insulin, 0.1 mg/ml cholera 
toxin, 10 ng/ml epidermal growth factor, 0.5% DMSO, 100 µg/ml streptomycin and 
100 U/ml penicillin G. A protocol communicated by Toropainen and co-workers [16] 
was slightly modified for our purposes. Briefly, cells were maintained for 1 week 
under liquid-covered conditions and were switched to an air-interface in the second 
week. Medium was changed every other day during the first week and daily in the 
second week.  
Caco-2 cells: The Caco-2 cell line was used as a comparison for the expression of 
ABC-transporters. Cells were purchased from LGC Promochem (Wesel, Germany) 
and used at passage numbers 23 to 25. Caco-2 cells were cultured in flasks until they 
reached confluence on day 7 using DMEM supplemented with 10% FBS and 1% non-
essential amino acids. The medium was changed every other day. 
 
The development of cells into monolayers of epithelial morphology was monitored 
microscopically. In addition, cell growth and integrity of cell layers was monitored by 
measurement of the transepithelial electrical resistance (TEER). Only cell layers with 
TEER values >400 Ω·cm2 were used for the transport experiments. The TEER values 
were assessed with an EVOM device equipped with STX-2 “chopstick” electrodes 
(World Precision Instruments, Berlin, Germany) and corrected for the background 
value of the blank filter. 
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Transport studies 
Drug transport studies were performed with both HCE-T cell layers grown on 
Transwell Clear filter inserts for 14 days and excised human cornea mounted in 
modified Ussing chambers [17]. All solutions used were prewarmed to 37°C. Prior to 
transport studies, the cell layers/tissues were equilibrated for 1 h in modified Krebs 
Ringer buffer (KRB, 1.5 mM K2HPO4, 3 mM KCl, 4 mM glucose, 142 mM NaCl, 
10.07 mM 4-(2-hydroxyethyl)-piperazine-1-ethanesulfonic acid (HEPES), 1.4 mM 
CaCl2, and 2.56 mM MgCl2, pH 7.4). The transport experiments were initiated by 
exchanging the KRB of the respective donor side with the same volume of KRB 
containing rhodamine 123 (Rh123; 13 µM final concentration). The apical and 
basolateral volumes were 500 µL and 1500 µL in the Transwell system and 2.5 ml 
(both sides) in the Ussing chambers, respectively. Two hundred µL samples were 
drawn from the corresponding receiver compartment every 30 min for up to 4 h. 
Removed volumes were replaced by the same amount of fresh pre-warmed KRB. To 
determine the initial donor concentration, 20 µL samples of the donor solution, taken 
at t = 0, were assayed.  
 
Fluorescence activity of Rh123 containing samples was analyzed in a 96-well plate 
reader (Cytofluor II, PerSeptive Biosystems, Wiesbaden, Germany) at excitation and 
emission wavelengths of 485 and 530 nm, respectively. These samples were diluted 
with KRB, where appropriate. 
 
Unidirectional Rh123 fluxes were also determined in the presence of cyclosporin A 
(CyA), an inhibitor of P-gp, to determine the effect of CyA on Rh123 transport. In 
these inhibition studies, all solutions contained a final concentration of 10 µM CyA.  
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For human cornea, the identical experimental protocol was used. Human corneas were 
mounted in modified Ussing chambers, allowing access to front and rear side of the 
tissue. Donor and acceptor volumes were altered to 2.5 mL for both compartments 
according to the capacity of the respective sides. The defective endothelium and 
stroma were not considered a critical barrier in the transport experiments. Exposure to 
CyA to the basolateral side of the epithelium was achieved by a 1 h preincubation of 
the tissue with KRB containing 10 µM of CyA. 
 
All experiments were performed in triplicates. For HCE-T cells, the same passage was 
used for all experiments. TEER values were assessed before and after the drug 
permeation experiments to ascertain the integrity of the corneas and the HCE-T cell 
layers. 
 
The apparent permeability of Rh123 was calculated using the equation,  
 
Ac
JPapp
*0
=    (Eq. 1) 
 
where J = Rh123 flux (mol/s), c0 = initial Rh123 concentration in the donor solution 
(mol/cm3) and A = surface area of the corneal tissue or HCE-T cell layers, which was 
1.27 cm2 or 1.13 cm2, respectively. 
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RNA isolation and RT-PCR 
Corneal rings were separated from the scleral rim, cut into 10 mm2 pieces and frozen 
in liquid nitrogen. Frozen tissues were then homogenized with an UltraTurrax 
homogenizer (IKA, Staufen, Germany). Subsequently, the nitrogen was evaporated 
and the residue was dissolved in lysis buffer (RNeasy kit). Further mincing of the 
corneal tissues was achieved by the use of a QiaShredder column (Qiagen). The lysate 
was purified for RNA according to manufacturer’s instructions. For extraction of 
cellular proteins and RNA from Caco-2 and HCE-T cells in culture, cells were 
washed twice with phosphate-buffered saline (PBS, 129 mM NaCl, 2.5 mM KCl, 7.4 
mM Na2HPO4•7 H2O, 1.3 mM KH2PO4, pH 7.4) and then treated with trypsin/EDTA 
(0.25%/1 mM) for 5 min. Isolated cells were then extracted for RNA using 
QiaShredder columns and the RNeasy kit. 
Reverse transcription was performed using the Omniscript kit in a Biometra Personal 
Cycler (Biotron GmbH, Göttingen, Germany) at 37ºC for 1 h followed by heating to 
95ºC for 5 min. Polymerase chain reaction was conducted for 35 cycles, using the 
primers listed in Table 1 and a temperature program of 94ºC for 10 min initially, 
followed by 94ºC for 30 sec, 55ºC for 30 sec, and 72ºC for 1 min. The final step 
consisted of 72ºC for 10 min and storage of the end product at 4ºC. The resultant 
DNA fragments were examined by agarose (2%) gel-electrophoresis. GAPDH was 
used as an internal “loading” control. 
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Table 1. Primer sequences for PCR (for = forward primer; rev = reverse primer) 
Primer Sequence 
P-gp (for) 5’-CCCATCATTGCAATAGCAGG-3’ 
P-gp (rev) 5’-GTTCAAACTTCTGCTCCTGA-3’ 
MRP1 (for) 5’-ATCAAGACCGCTGTCATTGG-3’ 
MRP1 (rev) 5’-AGAGCAAGGATGACTTGCAGG-3’ 
MRP2 (for) 5’-CAAACTCTATCTTGCTAAGCAGG-3’ 
MRP2 (rev) 5’-TGAGTACAAGGGCCAGCTCTA-3’ 
LRP (for) 5’-CCCCCATACCACTATATCCATGTG-3’ 
LRP (rev) 5’-TCGAAAAGCCACTGATCTCCTG-3’ 
BCRP (for) 5’-TGCCCAGGACTCAATGCAACAG-3’ 
BCRP (rev) 5’-ACAATTTCAGGTAGGCAATTGTG-3’ 
GAPDH (for) 5’-CCCCTGGCCAAGGTCATCCATGACAACTTT-3’ 
GAPDH (rev) 5’-GGCCATGAGGTCCACCACCCTGTTGCTGTA-3’ 
 
Immunofluorescence microscopy 
The respective antibodies were diluted 1:100 in PBS containing 1% (w/v) bovine 
serum albumin (BSA). For staining, corneal rings were cut into 10 mm2 pieces as 
described above. The specimens were fixed for 30 min with 2% paraformaldehyde 
and excess paraformaldehyde was then removed by a treatment for 10 min in 50 mM 
ammonium chloride solution, followed by permeabilization for 15 min with 0.1% 
(w/v) Triton X-100. After 60 min incubation with 100 µL of the diluted primary 
antibody at 37°C, the corneal pieces were washed three times before incubation with 
100 µL of a 1:100 dilution of a rabbit anti-rat IgG FITC-conjugate for LRP and a 
1:100 dilution of Alexa Fluor 488-labeled goat anti-mouse IgG for all other proteins 
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in PBS containing 1% (w/v) BSA. Propidium iodide (1 µg/ml) was used to 
counterstain cell nuclei. After 30 min incubation, the specimens were washed three 
times with PBS and embedded in FluorSafe anti-fade medium. A negative control 
included the use of a mouse IgG1,κ (Sigma, Steinheim, Germany) and the specimen 
treated according to the described procedure. Images were obtained with a confocal 
laser-scanning microscope (MRC-1024, Bio-Rad, Hemel Hempsted, UK) with the 
instrument settings adjusted so that no positive signal was obtained in the negative 
control. IFM for HCE-T cells grown on Transwell filter inserts was performed using 
the same protocol as described above. 
 
Statistical analysis 
Results are expressed as mean ± S.E.M. Significance (p < 0.05) of differences in the 
group mean values for TEER and Papp were determined by one-way analysis of 
variances (ANOVA), followed by Student-Newman-Keuls post-hoc tests. 
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Results 
Transport studies 
The apparent permeability coefficients (Papp) of Rh123 are shown in Figure 1. For 
both, human cornea and HCE-T cells, no significant net directionality of Rh123 fluxes 
could be observed. The presence of CyA did not alter the flux ratios, but CyA 
increased the absolute permeability values in both directions for the HCE-T cell 
layers. The respective Papp values (×10-7 cm/sec; mean ± S.E.M.; n = 3) for the 
different models/conditions were for human cornea, apical-to-basolateral (ab) 
2.23±1.50 and basolateral-to-apical (ba) 7.15±2.96. The addition of CyA changed the 
ab value to 4.87±0.78; and the ba value to 7.89±3.56. HCE-T cell layers showed an 
ab-Papp value of 11.90±3.00 and ba value of 17.00±2.80. The addition of CyA altered 
the ab-Papp to 32.20±5.53 and 39.10±2.60 (ba). 
 
RT-PCR 
RT-PCR studies were carried out to assess the mRNA expression profiles for P-gp, 
MRP1, MRP2, LRP, and BCRP. As shown in Figure 2, in excised human cornea only 
LRP produced a positive signal. No message for any other ABC-transporter under 
investigation could be detected. In comparison, the immortalized HCE-T cells did not 
show a signal for LRP mRNA, whereas signals for MRP1, MRP2, and BCRP could 
be detected. Caco-2 cells, which were used as control, expressed all mRNAs except 
for LRP.  
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Figure 1. Apparent permeability (Papp) of rhodamine (Rh123) across cultured layers 
of HCE-T human corneal epithelial cells (day 14) and excised human cornea. Excised 
human corneas were mounted in Ussing chambers and HCE-T cell layers were 
cultured on Transwell Clear filters for 14 days. Bi-directional transport studies 
(apical-to-basolateral (■) and basolateral-to-apical (□) directions) were carried out. 
No significant (p < 0.05) net directionality was found for Rh123 fluxes under all 
conditions tested. Presence of the P-glycoprotein inhibitor cyclosporine A (CyA) did 
not affect Rh123 flux ratios, but increased absolute fluxes across HCE-T cells. Data 
represent mean ± S.E.M. for n = 3 -4 
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Figure 2. Analysis of mRNA encoding for ABC-transporters by RT-PCR. The results 
for excised human cornea (lanes 2 to 6), HCE-T cells (lanes 7-12), and Caco-2 cells 
(lanes 14 to 19) are shown. GAPDH was used as an internal standard. Lane 1 shows 
the DNA ladder (ranging from 100 to 3000 bp). The bands for the amplicons are 
located on the gel at positions consistent with the expected sizes of 156 bp (P-
gp/MDR1), 181 bp (MRP1), 56 bp (MRP2), 405 bp (LRP), 171 bp (BCRP), and 518 
bp (GAPDH). In human cornea only the message for LRP was found, while HCE-T 
and Caco-2 cells contained mRNA encoding for MRP1, MRP2, and BCRP. Caco-2 
cells, in addition, contained mRNA for P-gp.  
 
Immunofluorescence microscopy 
The results of the IFM investigation are summarized in Figure 3. The presence of 
LRP in excised human cornea as a cytosolic vault protein was confirmed by IFM 
(Figure 3A). No signals for the other ABC–transporters under investigation could be 
observed by immunofluorescence (data not shown). IFM performed on Transwell-
grown HCE-T cell layers resulted in data, which are in support of the findings from 
the RT-PCR studies (Figure 3B, C, D). LRP was absent (data not shown), while 
strong signals could be obtained for MRP1 (Fig. 3B), MRP2 (Fig. 3C), and BCRP 
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(Fig. 3D). However, neither human cornea nor HCE-T cell layers showed expression 
of P-glycoprotein at the cellular membranes (data not shown). The negative control 
with a mouse IgG1, κ did not show any staining (data not shown) and thus verified 
successful immunofluorescence staining. 
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Figure 3. Immunolabelling of ABC transporter proteins in excised human cornea and 
Transwell-grown HCE-T cell layers. Staining for proteins (green) is shown using 
confocal laser scanning microscopy. Nuclei were counterstained with propidium 
iodide (red). A: LRP in human cornea; B: MRP1 in HCE-T; C: MRP2 in HCE-T; D: 
BCRP in HCE-T cells. 
C D 
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Discussion 
In this study, we investigated the presence of ABC-transporters in excised human 
cornea and HCE-T cell layers by means of bi-directional drug transport studies and 
methods of molecular cell biology. By choosing rhodamine 123 as substrate we 
mainly concentrated on the examination of P-gp. While the transport studies revealed 
no evidence for any such efflux system, we subsequently compared the expression 
profiles of other ABC-transporters in native human corneal tissue at mRNA and 
protein levels to those in the immortalized cell line, HCE-T. Our results show that in 
HCE-T cells, LRP was not found; instead MRP1, MRP2, and BCRP were expressed, 
as assessed by semi-quantitative RT-PCR and IFM studies. The process of 
immortalization is generally regarded as a critical step. During the process of 
immortalization, the life span of the cells is extended and the growth characteristics 
are enhanced. This procedure generally decreases the state of differentiation. 
Therefore, it may not be too surprising that new features can be introduced into the 
cells and possible features of earlier states of differentiation can be reactivated [18]. 
For example, BCRP has been reported to be present in corneal epithelial stem cells, 
but is absent in the differentiated corneal epithelial cells [19]. 
In contrast, LRP was found to be expressed in human cornea. LRP is considered a 
‘flag’ for the activation of an organic anion pump. LRP was also reported to be 
present in human tissues that are chronically exposed to xenobiotics, i.e., epithelial 
cells, supporting the assumtion that LRP is involved in the defense mechanisms of 
these cells [20]. It has been shown by Scherper and co-workers that LRP is a good 
drug-resistance-related predictor for the outcome of cancer treatments [21, 22], which 
makes these findings relevant for drug effect research. Due to its localization in the 
cytoplasm, effects of LRP on the Rh123 flux are not expected to affect the 
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directionality of transport across an epithelial cell layer, which is consistent with our 
findings.  
In the primary cultured cells of rabbit conjunctiva, the presence of P-gp has 
previously been reported [23]. The transporter protein was shown to be mainly 
located in the apical part of the epithelial cell layer and found to be an important 
impeding factor for the absorption behavior of lipophilic drugs [24]. Other 
compartments of the mammalian eye for which a P-gp expression was reported, 
include lens (rat) [25], conjunctiva (rabbit) [23] and cornea (rabbit) [26, 27]. MRP1 
has been reported for human retinal pigment epithelial cells [28], where it is 
functionally active.  
Our findings are in contrast to a previously published study conducted by Dey and co-
workers, who found evidence for the presence of P-gp/MDR1 mRNA in human 
corneal tissues [27]. While the difference in expression pattern between species is not 
entirely surprising, we have currently no explanation for the apparent discrepancy of 
their and our human data.  
So far, corneal cell models have not been compared to intact human cornea. The only 
system tested against human tissue is the human cornea construct (HCC) developed 
by Reichl and co-workers [29]. The HCC system is a multilayered, three-dimensional 
construct, composed of three different cell lines and aiming to mimic the entire 
cornea. Thus, it is not surprising that a close resemblance between the relatively 
complex human cornea construct and native cornea for the tested markers was found.  
In the present study, however, we compared human cornea with the HCE-T cell line. 
The results show that there are significant differences in the expression pattern of 
drug efflux transporters between the native tissue and such a reductionist corneal 
epithelial model. In summary, in spite of being relatively easy to use, the HCE-T cell 
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line might be only of high value as an in vitro model for the examination of passive 
transport processes, as the preliminary examinations presented in this study indicate 
differences in the ABC-transporter expression. 
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Introduction 
In addition to the experiments already evaluated in Chapter 1 to 4, further experiments were 
performed. These include the light microscopical examination of the used cell models and a 
comparison of the efflux protein expression in human cornea and the permanent HCE-T cell 
line using Western blotting. 
 
To evaluate the effect of the drug transport studies, the different in vitro models were 
evaluated microscopically after performance of transport experiments using a standard 
hematoxylin-eosin staining. 
Models under investigation were human cornea, rabbit cornea, HCE-T cells grown on 
Transwell filter inserts for 14 days as well as the Statens Serum Institute Rabbit Cornea 
(SIRC) in different stages of cell development and the Cambrex Clonetics human corneal 
epithelial cell model. 
The SIRC cell model was just examined for its growth behavior over 3 weeks because it does 
not exhibit tight junctions (shown by TEER measurements, values of ~ 90 Ω*cm² were 
recorded) and thus does not form a barrier significantly tight for drug transport. 
All other models were examined in their “native” state before the experiments and after 
performing the transport studies. An effect of the various compounds was tried to evaluate. 
 
To support the data on the gamut of ABC-transporter gamut in human cornea and HCE-T 
cells, immunoblotting experiments were performed. These experiments verified in part the 
data acquired through RT-PCR and immunofluorescence microscopy. Still, further 
experiments are needed to clarify the discrepancy between the immunoblotting data and the 
already shown data of chapter 4. 
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Materials and Methods 
Materials 
Sodium dodecylsulfate, mouse anti-P-gp antibody (clone F4), Quickdraw blotting paper, 
cholera toxin, bovine insulin, dimethyl sulfoxide (DMSO), formaldehyde and ethanol were 
from Sigma (Steinheim, Germany). Prestained wide-range protein markers were purchased 
from BioRad (Munich, Germany). Mouse anti-human MRP1 antibody (clone MRPm6), 
mouse anti-human MRP2 antibody (clone M2 III-6), and mouse anti-human BCRP antibody 
(clone BXP-21) were all purchased from Chemicon (Temecula, CA, USA). Rat anti-human 
LRP antibody (clone LMR5) was from Alexis (San Diego, CA, USA), anti-mouse IgG 
alkaline phosphatase (AP)-conjugate and anti-rat IgG AP-conjugate were from Promega 
(Madison, WI, USA). Protran BA-85 nitrocellulose transfer membranes were purchased from 
Schleicher & Schuell (Dassel, Germany). Eosin G 0.5% solution, Mayer’s hematoxylin 
solution, xylol, paraffin beads, Roti-Histokitt, Rotiphorese 30 acrylamide/bisacrylamide 
mixture, N, N. N’, N’ – tetramethylethylenediamine (TEMED), ammonium persulfate, 
glycine and tris-HCl were purchased from Roth (Karlsruhe, Germany). Complete mini 
protease inhibitor tablets and the AP substrate (NBT/BCIP) stock solution were from Roche 
Applied Sciences (Mannheim, Germany). Permeable filter inserts (Transwell Clear, 12 mm 
diameter, pore size 0.4 µm) were from Corning (Bodenheim, Germany). All other substances 
used were of highest grade available commercially. 
 
Tissue preparation and cell culture 
Excised human cornea: Non-transplantable human corneas, unsuitable for transplantation due 
to their low density of endothelial cells, and corneal rings were a gift from the Lions 
Corneabank (University Hospital, Homburg, Germany). Corneal rings were leftovers from 
successful cornea transplantations.  
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Caco-2 cells: The Caco-2 cell line was purchased from LGC Promochem (Wesel, Germany). 
Caco-2 cells (passages 23-25) were cultured in flasks using Dulbecco’s Modified Eagle’s 
Medium (DMEM) supplemented with 10% fetal bovine serum (FBS), and 1% non-essential 
amino acids. The medium was changed every other day. The development of cells into 
monolayers of epithelial morphology was monitored microscopically. The cells were grown 
until they reached confluence, which was achieved after a 7-day period. 
HCE-T cells: HCE-T cells were purchased from Riken Cell Bank (Tsukuba, Japan). HCE-T 
cells (passage numbers 75 to 84) were cultured on Transwell Clear filter inserts at a seeding 
density of 60,000 cells/cm². The culture medium consisted of DMEM/Ham’s F12 (1:1 
mixture) supplemented with 5% FBS, 5 µg/mL insulin, 0.1 mg/mL cholera toxin, 10 ng/mL 
epidermal growth factor, 0.5% DMSO, 100 µg/ml streptomycin and 100 U/ml penicillin G. 
As described earlier, cells were maintained for 1 week under liquid covered conditions and 
were switched to an air-interface condition in the second week. Medium was changed every 
other day during the first week and daily in the second week to contribute to the cell’s high 
metabolic activity. 
Clonetics corneal epithelial cell models: Clonetics cell culture models (Cat. No.: CMS-2015) 
were purchased from Cambrex (Vervier, Belgium). Upon arrival, cells were removed from the 
transport gel and transferred into the supplied 24-well cell culture plate. Cells were 
maintained under air-interface conditions with the provided, freshly supplemented cell culture 
medium (CEBM, Cat.No: CC-3251, supplemented with Corneal Epithelial SingleQuot kit, 
CC-4443). Maximum incubation time before the experiments was twelve hours. 
 
Methods 
Western blotting 
For immunoblotting, three groups of cell lysates were generated. The human corneal rings 
(1.7 cm in diameter; n = 4) were transplantation leftovers and consisted of a scleral part of 3 
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mm width and a corneal part approximately 4 mm wide. The scleral rim was carefully 
removed using a pair of scissors and forceps. The remaining corneal tissue was cut in pieces 
of 13.5 mm2 and frozen in liquid nitrogen, followed by homogenization using an UltraTurrax 
rotor-stator homogenizer. After evaporation of the nitrogen, the homogenized tissue was 
resuspended in 1 mL modified radioimmunoprecipitation (RIPA)-buffer with protease 
inhibitors (150 mM NaCl, 50 mM tris-HCl, 1 mM EDTA, 1 mM phenylmethylsulfonyl 
fluoride, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 µg/mL aprotinin, and 5 
µg/mL leupeptin; pH 7.4). The solution containing tissue homogenates was kept on ice for 30 
min and sonicated for 30 s every 10 min. After lysis, the suspension was centrifuged at 14,000 
rpm (20,000×g) at 4ºC for 4 min. An aliquot of the supernatant was taken for determination of 
protein amount and the remainder frozen for storage until assay later. A BCA-assay (Uptima, 
St. Augustin, Germany) was used for protein quantification. 
For the preparation of lysates from Caco-2 and HCE-T, cells were removed from the cell 
culture flask with trypsin/EDTA and washed with DMEM medium. The suspension of 
isolated cells was centrifuged and the cell pellet was resuspended in 1 mL RIPA-Buffer with 
protease inhibitors. The solution containing cells was kept on ice for 30 min and sonicated for 
30 s every 10 min. The cell lysate was then centrifuged at 14,000 rpm at 4ºC for 4 min. An 
aliquot of the supernatants was taken for protein determination and the remainder frozen 
immediately until use. 
For immunoblotting analysis, 20 µg each of the various protein lysates were diluted with 
reducing Laemmli’s sample buffer (130 mM Tris-HCl, 6% sodium dodecylsulfate, 20% 
glycerol, 0.1% bromphenole blue, and 10% β-mercaptoethanol, pH 6.8) to make up 30 µL of 
loading volume in each lane. Samples were denatured at 56ºC for 10 min and pipetted into 
each lane of the gel pockets. Electrophoresis was performed using a Mini Protean II (BioRad) 
at 80 V for 10 min and then at 100 V for 80 min to fractionate the proteins by their molecular 
weights. 
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For detection of P-gp, MRP1, MRP2, and BCRP, a 6% polyacrylamide gel was used with the 
wide range marker cocktail loaded in one lane. For the detection of LRP and GAPDH 
(internal standard), a 10% gel was used with wide range protein markers. Fractionated 
proteins were then transferred onto nitrocellulose membranes at 48 V for 2 h. Successful 
protein transfer was checked by Ponceau staining. The membrane was achromatized and 
blocked over night with blocking buffer containing 10% low fat milk and 0.1% Tween 20. 
Blocked membranes were incubated with the respective primary antibody diluted in blocking 
buffer for 90 min at room temperature. The membrane was washed for 2 min with PBS, twice 
with PBS containing 0.05% Triton X-100 for 5 min and again with PBS for 2 min. An 
appropriate AP-conjugated secondary antibody diluted in the blocking buffer was incubated 
with the membrane for 90 min at room temperature. After washing the membrane again as 
described above, the antibody-antigen complexes were detected with NBT/BCIP solution 
(Roche Applied Science, Mannheim, Germany). 
 
Histological staining 
A standard hematoxylin & eosin staining protocol was used. Briefly, cells were fixed in a 
formaldehyde solution (4% in PBS) at room temperature for 30 min. Excess formaldehyde 
was removed by repeated washing with water. Samples were then dyed with hematoxylin for 
about 20 min. The staining process was stopped by 4 to 5 washing steps with water. Washing 
was ceased after the washing liquid remained colorless. Samples were then dehydrated over 
night through a graded series of ethanol at 70%, 96% and 100% at room temperature and kept 
in xylol afterwards. For embedding, samples were soaked in paraffin wax at 60°C over night 
and embedded the next day. 
Four micrometer sections were cut with a microtome (Leica Microsystems, Nussloch, 
Germany) and stored in xylol. Samples were rehydrated by a graded series of ethanol at 
100%, 96% and 70% for 10 min each at room temperature. The sections were washed with 
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water and staining was intensified by another 5 min treatment with Mayer’s hematoxylin 
solution. No further staining was performed with HCE-T cell layers. Tissue samples of human 
cornea and rabbit cornea were counter-stained with Eosin G for 30 s and washed with a series 
of ethanol 96% and 100%. Sections were stored in xylene until mounting on object slides with 
Roti-Histokitt. Paraffin wax embedded sections were examined with a Zeiss Axiovert light 
microscope. (Carl Zeiss, Jena, Germany) 
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Results 
Protein expression 
Expression patterns of ABC transporter proteins were investigated by means of Western 
blotting. The immunoblotting partly confirmed the results obtained at the mRNA level and by 
immunofluorescence microscopy (see Chapter 4). Excised human corneal tissue shows 
positive signals for LRP only (Figure 1), while HCE-T cell layers express MRP1 and BCRP, 
but not LRP (Figures 1 and 2). Caco-2 cells, as expected, express P-gp/MDR1, MRP1, MRP2, 
and BCRP. 
 
Light microscopy 
Micrographs of the intact tissues are shown in Figure 3. Thickness of the epithelial cell layer 
varies with the type of tissue. In human cornea (Figure 3A) only four to five epithelial cell 
layers are recognizable. The stroma shows its characteristically collagen structure with 
implemented fibroblasts. Rabbit cornea (Figure 3B) shows similar features to human cornea. 
The epithelial cell layer shows a higher number of cell sheets and a progression in 
differentiation. This progress is visible by the change in morphology. 
HCE-T cells are only epithelial cells and therefore miss the stroma and endothelial cells. 
HCE-T cells on day 14 do not show much differentiation even though they grow in multiple 
layers (Figure 4A). 
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Figure 1. Representative Western blots of P-gp, MRP1, MRP2, and LRP. Lane 2 shows 
protein lysate from the excised human cornea, lane 3 control cell lysate (from Caco-2 cells), 
and lane 4 contains HCE-T cell lysate. Western blots for each of the ABC-transporters are 
representative of at least 2 independent experiments. 
 
 
Figure 2. Representative Western blots of BCRP and GAPDH (internal control). Lane 2 
shows protein lysate from the excised human cornea, lane 3 contains HCE-T cell lysate, and 
lane 4 control cell lysate (from Caco-2 cells). Western blots are representative of at least 2 
independent experiments. 
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The Clonetics model is also a reductionist model and consists of epithelial cells only. The 
cells grow in multiple layers of about 6 cell layers. A progress in differentiation is clearly 
visible through changed morphology (Figure 4B). 
 
The changes in model composition are shown in Figure 3 and 4. Changes are variable 
depending on the model and on the substance used. In general, it is visible that drug transport 
studies across corneal epithelium do affect the cell layers. In many cases, a disaggregation of 
the cells is visible. Also a swelling of the stroma can be detected in case of the human and the 
rabbit cornea. 
The proliferation of SIRC cell layers is shown in Figure 5. Pictures of the cell sheets were 
taken on day 7 (Fig. 5A), day 14 (Fig. 5B) and day 21 (Fig. 5C) 
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Figure 3: Ex vivo tissues before and after performance of transport experiments 
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Figure 4: In vitro cell layers before and after performance of transport experiments  
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Figure 5: Development of SIRC cell layers cultured on Transwell filter inserts for 21 days 
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Discussion 
Western blotting confirmed the data acquired by RT-PCR and immunofluorescence 
microscopy. Human cornea shows only a positive signal for LRP and BCRP, which has been 
reported to be a corneal stem cell marker [1]. HCE-T cells therefore show a broader spectrum 
of ABC-transporter proteins. MRP1 and BCRP were found by immunoblotting. LRP did not 
show any signal, which is in accordance to the data acquired earlier. Surprisingly, MRP2 was 
not found by western blotting, even though we clearly proved its presence by RT-PCR and 
immunofluorescence microscopy. This discrepancy might be due to instability of the 
antibody-antigen-complex or insufficient sensitivity of the detection method. Further 
experiments have to be carried out to clarify this matter. In any case, a successful blotting 
process was verified by the internal standard/loading control GAPDH. 
 
Differences in the morphology of the specimens have been detected by light microscopy. 
During drug transport studies, major changes occurred and were detected by post-transport 
light microscopy. In many cases, disaggregation of the cells and stroma were detected. In one 
case we also detected intensive signs of inflammation. If this inflammation was caused by the 
drug transport study or if the inflammation already existed prior to the experiment could not 
be determined in this experiment. Since ocular injuries often occur to breeded rabbits, it is 
reasonable to assume that the inflammation already existed at beginning of the experiment. 
Major disaggregation was also detected in the HCE-T cell model indicating that these cell 
layers have an integrity shift during transport experiments. These findings are in accordance 
to the recorded TEER values, that usually show a mean drop of about 200 Ω*cm². 
Since the TEER values were still in the range of about 300 Ω*cm² for all cell layers used in 
experiments, a lack of cell layer tightness is not probable. Still, changes in cell tightness and 
cell layer adherence are to be taken in account. 
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Conclusions 
The presented work gives a thorough overview on „state of the art“ in vitro cell cultures of the 
corneal epithelium. 
The initial aim of this study, setting-up a primary corneal epithelial cell culture model based 
on human tissue, however, was not achieved. As other researchers in the field, we found that 
major obstacles, such as too little tissue amounts and poor viability of the cells in the corneal 
epithelium, circumvent the successful continuous culturing of these cells to tight monolayers. 
Recent advantages in cell isolation techniques are still to inefficient to promote cell 
accumulation for this specific tissue. 
 
For the examination of the penetration behavior of moxaverine-hydrochloride (Mox), we 
found in different models (rabbit in vivo, primary rabbit corneal epithelial cell culture, human 
ex vivo, rabbit ex vivo, human in vitro corneal epithelial cell culture) unisonous data that 
cornea does not represent a critical barrier for the ocular delivery of this drug. However, the 
low solubility in aqueous solutions of physiological pH presents a major obstacle on the way 
to successfully market moxaverine-HCl as a topically-administered medicine. 
 
In this thesis, I was able to evaluate a number of different in vitro models of the corneal 
epithelium. I found that those models that were mainly established as substitutes for the 
Draize test disqualify for drug transport studies due to their lack of functional cell-cell 
contacts. Nevertheless, these models are of high value for eye irritation assays. Systems that 
were developed with the aim to provide tight cellular layers (i.e., HCE-T and the Clonetics 
corneal epithelium model) are useful tools to assess passive corneal transport. However, for 
active transport, the HCE-T model should be used with caution, since it was found in the 
cause of my studies that the spectrum of ABC-transporter proteins significantly differs from 
native human cornea. The Clonetics human corneal epithelium should also be used with care, 
130 
Conclusions, Summary and Outlook 
because its ABC-transporter spectrum has not been assessed so far. The SIRC cell line does 
neither form tight cell layers nor matches the human corneal morphology and should thus not 
be used for drug transport studies at all. 
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Summary  
The focus of my thesis was to find a simple test system to screen new therapeutic entities to 
regarding their ocular penetration. Using the model compound moxaverine-hydrochloride, the 
project was performed in 4 phases: 
 
In phase 1, the tissue distribution of moxaverine-hydrochloride in the rabbit eye was 
examined and evaluated. A distribution profile was generated by either dosing pigmented 
Dutch-belted rabbits topically on the eye or applying the drug solution intravenously. Results 
showed that high drug amounts in the posterior part of the eye can be achieved after pre-
corneal disposition of the moxaverine-solution. The fact that blood-plasma levels of 
moxaverine-hydrochloride did not exceed the levels found after systemic dosing makes local 
ocular administration of moxaverine-hydrochloride an interesting therapeutic approach. 
Parallel to the in vivo testing, the barrier that corneal epithelium exhibits towards moxaverine-
hydrochloride was examined using a primary rabbit corneal epithelial cell culture (rbCECL). 
These in vitro drug transport studies confirmed that the rabbit cornea does not represent a 
critical barrier for moxaverine-penetration into the eye. 
 
Phase 2 of the presented project dealt with the development of a primary human corneal 
epithelial cell model. Many attempts of creating such a model have been described frequently 
throughout the last decades. Even though scientists often succeeded in isolating cells and 
setting up primary cell cultures, cell isolation proved unreliable and cumbersome in all cases. 
Since significant progress has been made in recent years in our understanding of cell isolation 
and culture, applying these techniques to the human corneal epithelium seemed feasible. 
The methods mainly concentrated on various enzymatic digestions, using proteases and 
combination of these enzymatic techniques with a cell positive selection protocol using 
magnetic microbeads coated with human epithelial antigen (CD327, HEA-125). Even though 
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the experimental conditions were varied intensively and numerous combinations of enzymes 
were examined, the aim of the primary human corneal epithelial cell culture was not reached. 
The limited amount of available tissue and the long storage time of the corneal samples after 
excision might contribute to the failure of this part of the work. 
 
Since a primary human corneal epithelium was out of reach as an in vitro test system, existing 
models of human corneal epithelium were examined and compared to intact human and rabbit 
cornea (phase 3 of the thesis). The cell models under investigation were all of human origin 
and immortalized by either SV-40 large T antigen or a recombinant retrovirus containing 
HPV16 genes E6 and E7. The cell models were examined by a spectrum of marker-substances 
for their power to differentiate (high/low permeability markers), presence and activity of P-
glycoprotein efflux systems (using substrate molecules), and value for ophthalmic research 
(“ophthalmology marker”). The systems were also used to screen the substance of interest, 
moxaverine-hydrochloride. 
Using a set of marker substances, a ranking of the models was created. The commercially 
available reconstituted human corneal epithelium from Skinethic (Nice, France) showed a 
poor performance in this study, even though it serves as a valuable tool in toxicity and eye 
irritation testing. The likewise commercially available Clonetics system from Cambrex as 
well as the long established HCE-T cell line proved to be good simplified models of the 
cornea. Drawbacks for the HCE-T cell line, however, is the less pronounced power of 
differentiation and the findings made in stage 4 of the project (see below). 
 
In the final, fourth phase of the project, the HCE-T cell line was compared to the human 
cornea regarding its equipment with common efflux transporters. Since efflux systems of the 
ABC-transporter family are known to be a crucial factor in drug disposition and failure in 
cancer therapy, these proteins have gained major interest in biopharmaceutical research.  
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To clarify the situation in corneal epithelium that has not been extensively reviewed so far, we 
examined the presence of MDR1/P-gp, MRP1, MRP2, LRP, and BCRP in ex vivo human 
corneal samples and the commonly used HCE-T cell line. RT-PCR and immunofluorescence 
microscopy, as well as immunoblotting were used as tools to assess the spectrum of 
transporters. 
Human cornea proved to be a rather uncritical tissue concerning multi-drug resistance issues, 
showing only a little array of efflux proteins, namely only LRP, HCE-T, however, showed a 
broader spectrum of efflux proteins, not unexpected in a continuously growing cell line that 
highly differs from the situation found ex vivo. These finding somewhat reduce the value of 
the HCE-T model in drug transport research. 
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Zusammenfassung 
Die vorliegende Arbeit konzentrierte sich auf das Erforschen eines einfachen Testsystems, um 
das oculare Penetrationsverhalten neuer therapeutischer Substanzen vorhersagen zu können. 
Unter Verwendung der Modellsubstanz Moxaverin-Hydrochlorid wurde das Projekt in 4 
Abschnitten durchgeführt:  
 
In Phase 1 wurde die Gewebeverteilung von Moxaverin-Hydrochlorid im Kaninchenauge 
ermittelt und bewertet. Ein Verteilungsprofil wurde erstellt, indem pigmentierte Kaninchen 
der Rasse “dutch-belted” eine Wirkstofflösung entweder lokal am Auge oder intravenös 
verabreicht wurde. Die Resultate zeigten, daß hohe Substanzmengen im hinteren Teil des 
Auges nach precornealer Verabreichung der Moxaverinlösung erreicht werden können. Die 
Tatsache, daß die Blutplasma-Spiegel des Moxaverin-Hydrochlorids die der systemischen 
Gabe nicht überstiegen, macht die lokale, okulare Gabe von Moxaverin-Hydrochlorid zu einer 
interessanten Therapiemöglichkeit für die vom Koopertionspartner vorgesehene 
Anwendungsgebiete. Parallel zur in vivo Testung wurden die Barriereeigenschaften des 
Korneaepithels gegenüber Moxaverin-Hydrochlorids mit einer primären Epithelzellkultur der 
Kaninchenkornea (rbCECL) überprüft. In vitro Arzneistofftransportstudien zeigten, daß das 
Kaninchenhornhautepithel keine kritische Barriere für die Moxaverinpenetration in das Auge 
darstellt.  
 
Phase 2 der vorgelegten Arbeit beschäftigte sich mit der Entwicklung eines primären 
humanen Korneaepithelzellmodells. Versuche, ein derartiges Modells zu etablieren, sind 
bereits mehrmals während der letzten Jahrzehnte beschrieben worden. Obwohl die 
Wissenschaftler häufig erfolgreich Zellen isolieren und Primärzellkulturen etablieren konnten, 
stellte sich die Zellisolation bisher stets als unreproduzierbar und mühsam heraus. Da sich die 
Techniken in den letzten Jahren deutlich weiterentwickelt haben und zahlreiche Protokolle z. 
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B. für primäre menschliche alveolare Zellekulturen erstellt wurden, erschien die 
Übertragbarkeit dieser Methoden auf das menschliche Korneaepithel möglich. Die 
angewandten Techniken bestanden hauptsächlich aus enzymatischen Verdau mittels 
verschiedener Proteasen, die bereits in der Literatur beschrieben wurden. Diese wurden mit 
einem Zell-Aufreinigungsverfahren kombiniert, das sich magnetischer Microbeads bedient. 
Diese sind mit einem menschlichem Epithelantigen (CD326, HEA-125) beschichtet und 
besitzen die Möglichkeit, spezifisch an humane Epithelzellen zu binden. Obwohl die 
experimentellen Bedingungen immer wieder variiert wurden und verschiedene 
Isolationstechniken kombiniert wurden, konnte das gesetzte Ziel der primären menschlichen 
Korneaepithelzellkultur nicht erreicht werden. Die begrenzte Menge des vorhandenen 
Gewebes und die lange Kulturzeit der Korneaproben nach Entnahme aus dem Spender trugen 
hierbei massgeblich zum Misslingen dieses Teils der Arbeit bei.  
 
Da ein primäres menschliches Korneaepithel als in vitro Testsystem nicht verfügbar war, 
wurden bereits etablierte Modelle für das menschliche Korneaepithel mit intakter Menschen- 
und Kaninchenhornhaut verglichen (Abschnitt 3 des Projekts). Alle untersuchten Zellmodelle 
waren menschlichen Ursprungs und durch das SV-40 large T Antigen oder ein recombinantes 
Retrovirus, das die HPV16 Gene E6 und E7 enthielt, immortalisiert. Die Zellmodelle wurden 
mit einem Spektrum von Testsubstanzen auf ihre Differenzierungskapazität (hoher/niedriger 
Permeabilitätsmarker), das Vorhandensein von P-gp Effluxsystemen (mittels 
Substrattransportes) und Wert für die Augenforschung („Ophthalmologiemarker“) überprüft. 
Die Systeme wurden weiterhin als Screen für die Modellsubstanz, Moxaverin-Hydrochlorid, 
benutzt. Mittels dieser Markersubstanzen wurden die Zellmodelle klassifiziert. Das käuflich 
erhältliche rekonstituierte menschliche Korneaepithel von Skinethic (Nizza, Frankreich) 
zeigte nur eine niedrige Differenzierungsleistung, obwohl es ein wertvolles Testsystem im 
Bereich Augenreizung und Toxizitätsstudien darstellt. Das ebenfalls kommerziell erhältliche 
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Clonetics System von Cambrex und die etablierte HCE-T Zelllinie waren gute vereinfachende 
Modelle der Hornhaut. Die HCE-T Zelllinie zeigte allerdings weniger ausgeprägte 
Unterscheidungskraft als das Clonetics System und die Resultate die in Phase 4 des Projektes 
(siehe unten) gefunden wurden, führten zu einer weiteren Rückstufung des Modells. 
 
In der letzten, vierten Stufe dieser Arbeit wurde die HCE-T Zelllinie mit der menschlichen 
Hornhaut bezüglich der wichtigsten bekannten Effluxsysteme verglichen. Da die 
Effluxsysteme der ABC-Transporterfamilie sich als entscheidender Faktor in der 
Arzneistoffabsorption über biologische Barrieren herausgestellt haben und auch eine 
entscheidende Rolle in der Resistenzbildung von Tumoren in der Krebstherapie spielen 
(„mulit-drug resistance“), haben diese Proteine ein grosses Interesse in der 
biopharmazeutischen Forschung geweckt. Da es zum Expressionsmuster der ABC-
Transporter in der menschlichen Hornhaut nur wenige und zudem widersprüchlich Aussagen 
gibt, wurde das Vorhandensein und die Aktivität von MDR1/P-gp, MRP1, MRP2, LRP und 
von BCRP in Humankornea mit in der vielgenutzten HCE-T Zelllinie verglichen. RT-PCR 
und Immunofluoreszenzmikroskopie, sowie Immunoblotting wurden hierbei als Methoden 
benutzt. Menschliche Hornhaut stellte sich hierbei als ein ziemlich unkritisches Gewebe 
bezüglich multidrug-resistance Proteinen dar und zeigte ein sehr eingeschränktes Spektrum an 
Effluxproteinen (LRP). HCE-T Zellen, stattdessen besitzen ein breites Spektrum von 
Effluxtransportern, das sich in hohem Grade von der in vivo Situation unterscheidet. Dies 
mindert deutlich den Wert dieser Zelllinie als in vitro Modell für die Erforschung von 
(aktivem) Arzneistofftransport. 
137 
Conclusions, Summary and Outlook 
Outlook 
For the future, the picture on in vitro models of the human corneal epithelium still has to be 
refined. This work found good correlations for passive transport across some of the in vitro 
models which were able to give a clear rank order of the marker compounds under 
investigation, however, the question of active transport is still not completely elucidated. First 
examinations on human cornea and the HCE-T cell line have been performed, but do not 
cover the whole spectrum of efflux proteins.  Neither have the other model systems been 
investigated in this regard. 
Other topics that need to be addressed are the comparison of the cell culture models with the 
meanwhile available human corneal constructs  
Based on recently published date these cornea constructs systems might be promising tools 
for the testing of drug formulations, safety testing/risk assessment of formulations, and 
questions of penetration enhancement and enhanced drug retention on the ocular surface. 
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List of abbreviations 
 
AIC Air-interfaced culture 
BCRP breast cancer resistance protein 
BSS Balanced salt solution 
C-HCE Clonetics human corneal epithelium 
CLSM Confocal laser scanning microscopy 
CyA Cyclosporin A 
DMEM Dulbecco’s minimum essential medium 
DMEM/F12 1:1 mixture of DMEM and Ham’s F12 medium 
EDTA (Ethylenedinitrilo) tetraacetic acid, disodium salt 
EGF Epidermal growth factor 
EHC Excised human cornea 
ERC Excised rabbit cornea 
EVOM Epithelial volt-ohm meter 
FBS Fetal bovine serum 
FluNa Fluorescein-sodium 
HCE-T SV40-transfected human corneal epithelial cells 
HEPES 4-(2-Hydroxyethyl)-piperazine-1-ethansulfonic acid 
KRB Krebs-Ringer buffer 
LCC Liquid-covered culture 
LRP lung resistance-related protein 
MDR Multi-drug resistance 
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MEM Minimal essential medium 
Mox/MOX Moxaverine-hydrochloride 
MRP multi-drug resistance-associated protein 
NEAA Non-essential amino acids 
P-gp P-glycoprotein 
Papp Apparent permeability 
PBS Phosphate buffered saline 
PD Potential difference 
Prop Propranolol 
rbCrECL Rabbit corneal epithelial cell layers 
Rh123 Rhodamine 123 
RT-PCR Reverse transcription polymerase chain reaction 
S-HCE Reconstituted human corneal epithelium (Skinethic) 
S-MEM supplemented MEM 
TEER Transepithelial electrical resistance 
Tim Timolol-hydrogenmaleate 
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